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 3 
1 Introduction 
 
1.1 Overview on molecular biology of copper homeostasis 
 
Copper (Cu) is a redox-active metal ion than can exist in two forms, Cu(I) and Cu (II). 
Copper is an essential trace metal in biology employed as a catalytic and structural cofactor in 
many metalloproteins involved in different biological processes such as energy generation, 
iron transport, signal transduction, blood coagulation and more (Kim et al., 2008). It is likely 
that thus far only a part of the copper binding proteins have been discovered and 
characterized, since by bioinformatics analysis Andreini et al. (2008) estimated that around 
1% of the total bacterial and eukaryotic proteomes is composed by Cu binding proteins. 
It is well known that given its redox properties copper can also lead to toxicity especially in 
case of over accumulation (Gaetke and Chow CK, 2003). Not surprisingly all organisms have 
evolved a complex and efficient machinery to uptake, distribute and excrete this metal, 
leaving no free copper ions in the cell (Rea et al., 1999). 
The inability to control Cu balance is associated with genetic diseases of overload and 
deficiency and has recently been tied to neurodegenerative disorders and fungal virulence 
(Kim et al., 2008). 
In general proteins involved in copper homeostasis can be divided in two main and broad 
categories: copper chaperones and membrane transporters. 
Copper delivery and distribution within the cell is mediated by a family of proteins termed 
metallochaperones that function to provide copper directly to target pathways while protecting 
this metal from intracellular scavenging (O'Halloran and Culotta, 2000). 
Copper membrane transporters are membrane integral proteins that mediate the copper 
transfer across biological membranes (Prohaska, 2008).  
In the current model of copper homeostasis in higher organisms Ctr1 (Copper transporter 1 
represents the main route of copper entry into the cells. Despite Ctr1 is the only high affinity 
copper transporter identified so far, two lines of evidence suggest the existence of Ctr1 
alternative copper uptake pathway: embryonic fibroblast Ctr1 null exhibits a residual (around 
25% compared to wild type fibroblast) copper uptake activity (Lee et al., 2002b) and mice 
heterozygous for Ctr1 exhibit copper accumulation defects only in specific tissues (Kuo et al., 
2001; Lee et al., 2001).  
Recently a role for Ctr2 in mobilizing intracellular copper stores or mediating copper uptake 
from the plasma membrane was proposed (van den Berghe et al., 2007; Bertinato et al., 2008). 
Once copper enters in the cytoplasm it can be directed to three main routes (Fig. 1). 
The first involves copper delivery to the mitochondria. The matrix of this compartment has 
been shown to contain a Cu storage pool that can be used either for the metallation of the two 
more abundant copper binding mitochondrial proteins, CcO (cytochrome C oxidase) and 
SOD1 (Superoxidase dismutase) or for export into the cytosol (Cobin et al., 2004, Cobin et 
al., 2006).  
A central actor in this pathway is the copper chaperone Cox17 (Cytochrome c oxidase 17), 
located in the mitochondrial membrane space, which is required for Cytochrome Oxidase 
assembly and has been proposed to deliver copper to CuB of Cox1 (Cytochrome c oxidase 
complex 1) via Cox11 (Cytochrome c oxidase 11), and to CuA of Cox2 (Cytochrome oxidase 
complex 2) via Sco1 (Cynthesis of cytochrome c oxidase 1) ( (Horng et al., 2004).  
In mammals Cox17 is an essential protein, indeed Cox17 null mice are embryonic lethal 
(Takahashi et al., 2002). Mitochondrial copper levels are unchanged in yeast cells depleted for 
Cox17, therefore other biomolecules delivering copper to these organelles must exist. The 
authors proposed that the same ligand binding copper in the matrix act as a copper shuttle in 
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and out the mitochondria (Cobin et al., 2004; Cobin et al., 2006). The biochemical nature of 
such ligand is currently under investigation.  
The second route is the delivery of copper to the Golgi compartment, where the metallation of 
holo newly synthesized metalloproteins takes place, turning them into the active and final apo 
forms.  
Two main proteins involved in copper delivery to the Golgi lumen have been characterized: 
Atox1 (Antioxidant protein 1) is cytosolic copper chaperone that delivers copper by direct 
interaction to ATP7a and ATP7b, which in turn mediate the transfer of the metal across the 
Golgi membranes (Hamza et al., 1999). The copper mediated interaction between Atox1 and 
N-terminal domain ATP7 (ATPase) is probably the most studied and best structurally 
characterized example of delivery of copper from one protein to another (Wernimont et al., 
2000; Banci et al., 2006; Banci et al., 2009). 
Atox1, as Cox 17, is essential for embryonic development (Hazma et al., 2003) and very 
recent publications suggest an alternative role for Atox1 in copper homeostasis as copper 
responsive transcription factor involved in cell proliferation  (Itoh at al., 2008; Itoh et al., 
2009). 
ATP7a and b are copper specific P(1B)-type ATPases (Argüello et al., 2007) that have been 
extensively studied during the last two decades. These transporters are not only involved in 
copper delivery to the secretory pathway but play an essential role in excreting copper excess 
out of the cells and tissue (Lutsenko et al., 2008). Indeed mutations of ATP7a lead to Menkes 
disease, a X-linked lethal disorder characterized by intestinal Cu overaccumulation and 
concomitant copper deficiency in peripheral tissues, while mutations of ATP7A are 
responsible for Wilson’s disease, an autosomal recessive disease characterized by 
hepatotoxicity and neurotoxicity due to copper overload in these tissues (Madsen and Gitlin, 
2007). 
The third pathway is the delivery of copper to cytosolic proteins, the most abundant of which 
is SOD1.  
A copper chaperon renamed CCS (copper chaperon for SOD1) mediates post-translational 
SOD1 activation by copper loading and oxygen dependent formation of an intra-molecular 
disulfide bond in the enzyme (Brown et al., 2004; Furukawa et al., 2004). These observations 
are consistent with a role for CCS in activating SOD in response to oxidative stress.  
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease caused by distinct 
mutations in the SOD1 gene, all causing neurotoxicity. Despite many mutations causing the 
disease have been mapped some of them do not seem to affect the biochemical and enzymatic 
activities of SOD1 (Potter and Valentine, 2003). Recently in mouse model for ALS the 
overexpression of CCS was associated with mitochondrial pathology acceleration of the 
disease course (Son et al., 2007), suggesting that this protein could have a role in this disease. 
Both CCS and SOD1 are found not only in the cytosol but also in the mitochondrial 
intermembrane space (IMS), from where they probably protect the cells by the superoxide 
ions during the mitochondrial electron transport reactions (Sturtz et al., 2001). 
CCS differently from Cox17 and Atox1 is not an essential protein interestingly CCS null mice 
are viable and retain partial SOD1 activity, suggesting the existence of CCS copper loading 
and SOD1 independent activation pathway (Wong et al., 2000). Several lines of evidence 
support confirm this hypothesis, in particular the genome of the worm Caenorhabditis 
elegans does not code for CCS but this organism synthesizes fully active forms of the enzyme 
(Jensen and Culotta, 2005). Metallation of extracellular SOD (eSOD or SOD3) a form 
secreted in the extracellular environment has been shown to be dependent on the 
Atox1/ATP7a pathway (Qin et al., 2006).  
This observation and the lack of observed CCS localization to the TGN suggest the possibility 
that the CCS independent SOD1 metallation/activation may take place in the secretory 
pathway.  
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CCS expression levels are inversely proportional to copper availability; indeed copper excess 
leads to a proteasome dependent degradation of the CCS (Bertinato J, L'Abbé MR). Despite 
this regulation has been shown to be uncoupled from the ability to load copper onto the 
apoSOD1 (Caruano-Yzermans et al., 2006) the role of this regulation in copper homeostasis 
in not well understood. 
MT (Metallothionein) is a low molecular weight (6-7kDa) non-enzymatic protein ubiquitous 
in the animal kingdom that performs a wide array of biological functions (Carpene’ et al., 
2007).  Its central role in copper is highlighted by studies that suggest the importance of this 
protein as copper sink in case of copper hyper accumulation (Suzuki, 1995) as well as its 
protective role, not yet elucidated, during copper starvation (Ogra et al., 2006). The partners 
that interact and exchange copper ions with metallothioneins have not been yet identified.  
Many questions regarding molecular machinery regulating copper homeostasis still need to be 
answered, but probably the “one million dollar” in this research field is how the cells can 
sense even minimal variations in copper concentration. Despite many researchers have 
hypothesized the existence of a “copper sensor” such protein has not been identified yet.  
 
 
 
 
Figure 1. Schematic representation of copper homeostasis in animal cells. 
 
 
 
1.2 Copper transporter (Ctr) proteins 
 
 
In the last decades studies developed by many groups have succeeded in the identification of 
proteins belonging to the Ctr family throughout the whole eukaryotic kingdom.  
Ctr proteins are the only high affinity copper transporter identified so far in higher organisms, 
but their mechanism of action is still unknown. 
The first Ctr protein was described and characterized in yeast during the early 90s (Dancis et 
al., 1994) and since then this organism has been a model to identify through complementation 
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studies Ctr hortologues in plants (Kampfenkel at al., 1995) in human (Zhou and Gitschier, 
1997), mouse (Lee et al., 2000) and lizard (Riggio et al., 2002). 
Recently by informatic approach (Dumay et al., 2006) it was observed that despite length of 
the Ctr protein can greatly vary among different species, all Ctr sequences share two 
characteristic features (Fig. 2a): 
 
1) the presence of three putative transmembrane domains (TMD) the first distant from 
the second two, which are close to each other in the linear sequences of these proteins. 
2) a very high conserved aminoacid sequence located between TMD2 and TMD3 
(Dumay et al., 2006): 
(YF) (Hy)2 M (Hy)3 M (TSY) (YF) N X2 (Hy)8 G (Hy)3 G X (Hy)3  
where Hy are hydrophobic residues and X are any residues. 
 
 
 
 
Figure 2. a) Schematic representation of topology of the Ctr1 monomer highlighting the three TMDs 
and Met-rich and Cys-His putative copper binding sites. b) Model for Ctr1 trimer embedded in the 
plasma membrane.  
Reprinted by permission from Macmillan Publishers Ltd: Nature Chemical Biology. Kim BE, 
Nevitt T, Thiele DJ. Mechanisms for copper acquisition, distribution and regulation. Nat Chem 
Biol, 2008;4(3):176-8), copyright 2008. 
 
 
 
Furthermore while genomes of lower eukaryotes contain usually three or more members 
belonging to this family, vertebrates code for no more than two Ctr proteins (Dumay et al., 
2006). 
Ctr mediated high affinity copper transport was demonstrated mainly by studies involving 
incorporation of Cu64 in different cell lines (Lee et al., 2002a; Eisses and Kaplan, 2005b). 
In the last decade human Ctr1 (hCtr1) has become the model to elucidate structure, regulation 
and physiological role of these proteins in copper homeostasis of these proteins in vertebrates. 
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1.2.1 Human Copper transporter 1 (hCtr1) structure  
 
Only very recently the structure of the hCtr1 has been resolved by electron crystallography, 
confirming what previously hypothesized, that three hCtr1 molecules pack tail-to-tail forming 
a pore at the center of the trimer (Lee et al., 2002a; Eisses and Kaplan, 2002). 
Each monomer spans the membrane layer three times forming a cone shaped pore: at the 
extracellular end, the pore is narrow and only the TMD2 from each monomer contributes to 
its lining, while following rearrangement of helix packing at the intracellular end it widens 
with all three TMD distributing evenly around it define its shape (De Feo et al., 2009) as 
shown in Fig. 3.  
The TMD3 helix, almost perpendicular to the membrane plane, is connected to TMD2 by a 
short loop, only three aminoacids, on the extracellular sides, and can approach the helix in the 
TMD1 very tightly, supporting the idea that is important for helix packing, as previously 
suggested by mutation analysis of the very well conserved GXXXG motif in this domain 
(Aller et al., 2004).  
 
 
 
Figure 3. A) Tridimensional side view of hCtr1 trimer. Red asterisk indicates the short extracellular 
loop between TMD2 and TMD3. The main copper binding sites are reported. B) Schematic view of 
the conical shape of the pore with the copper binding sites. C-D-E) Cross sections of the trimer helix 
arrangement at the extracellular side. (C) in the middle of the bilayer (D) and at the intracellular side 
(E).  
Reprinted by permission from, PNAS; De Feo CJ, Aller SG, Siluvai GS, Blackburn NJ, Unger 
VM. Three-dimensional structure of the human copper transporter hCTR1. Proc Natl Acad Sci 
U S A. 2009, copyright 2009. 
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The methionines in the MXXXM motif, conserved in all Ctr proteins and located at the 
extracellular end of TMD2 (Fig. 2b and 3) reside in close apposition to each other. 
Substitution of either of the two methionine residues in the MXXXM motif by alanine or 
serine residues abolishes yeast Ctr1 and human Ctr1 mediated copper transport activity, while 
conversion in cysteine or histidine residues does not significatively affect copper uptake (Puig 
S et al., 2002; Eisses and Kaplan, 2005b). It is likely that such motif participates in the 
formation of a copper binding site, which probably acts as a selective filter similar for the 
metal. A similar model was described for K-channels (Doyle DA et al., 1998). 
Several lines of evidence suggest that binding of Cu to this motif may induce a 
conformational switch, and such switch could trigger internalization from plasma membrane 
since mutation of either methionine residues in the group abolishes hCtr1 clearance from cell 
surface following high extracellular copper concentration (Guo et al., 2004). 
Each hCtr1 trimer contains two additional copper binding sites located at the opposite ends of 
the pore. One extracellular coordinated by the methionines in the MPM sequence in the N-
terminal (Puig et al., 2002; Eisses and Kaplan 2005b), and one intracellular coordinated by the 
Cys HCH sequence in the C-terminal (Xiao et al., 2004; Wu et al., 2009).   
The authors showed by inductive plasma-optical emission spectroscopy (ICPOES) coupled to 
X–ray spectroscopy that the hCtr1 trimer can simultaneously bind two Cu(I) through these 
three distinct binding sites and both ions are coordinated by three Cu-S thioether bounds (De 
Feo et al., 2009), typical of copper exchange reactions mediated by intracellular copper 
chaperones and their target (Davis and O'Halloran, 2008). 
The authors propose a model where copper moves through the pore by exchange reactions 
between distinct binding sites and these reactions induce conformational switches (De Feo et 
al., 2009). Given the higher thermodynamic stability of Cu(I)-Cys coordination than the 
Cu(I)-Met coordination, the C-term intracellular copper binding site residues would provide a 
thermodynamic sink, allowing transport of copper in ATP independent way (Puig et al., 
2002). 
Other conserved residues have been studied by mutagenesis. His-139 is probably involved in 
interaction between monomers more than contributing to form a copper-binding site (Eissen 
and Kaplan, 2005b; De Feo et al., 2009). Methionines, in particular a MXXXM motive and 
His-rich regions in the N-terminal have been associated with high affinity transport (Puig et 
al., 2002). 
 
 
 
1.2.2 Ctr1 transcriptional regulation  
 
In yeast, the 5’ regulatory regions of the CTR1, CTR3 and FRE1 genes contain a CuRE (Cu 
responsive element) element that is essential for transcriptional up-regulation in response to 
copper starvation and also for repression under conditions of copper excess (L’Abbe et al., 
1998). The MAC1 (Metal-binding activator) transcription factor can bind to CuRE elements 
in copper transport pathway genes, modulating transcription in response to copper starvation 
(Yamaguchi-Iwai et al., 1997). Copper dependent transcriptional regulation in higher 
organisms is still controversial.  Vertebrate do not code for a MAC1 homologue and hCtr1 
mRNA levels do not seem to change as a function of copper state as reported for liver and 
intestinal mucosa of adult mouse (Lee et al., 2000) and intestinal human cells (Tennant and 
al., 2002; Bauerly et al., 2002). 
So far in vertebrate copper dependent Ctr1 transcriptional regulation was reported in 
specimens of Sparus aurata exposed to copper. While dietary copper induced a decrease in 
trascriptional levels of expression of Ctr1 in the intestine and liver, waterborn copper 
exposure induced an increase Ctr1 mRNA levels in the intestine and the kidney (Minghetti et 
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al., 2007). The authors hypothesize that this differential regulation may be required in fish to 
cope with two different routes for copper acquisition in these animals. 
Recently it was shown that the hCtr1 promoter contains three binding sites for transcription 
factor Sp1 (Sp1 transcription factor) and that zinc finger domain of Sp1 functions as a sensor 
of Cu that regulates hCtr1 transcription levels in response to Cu concentration variations 
(Song et al., 2008). The low magnitude of these changes in hCtr1 mRNA expression may 
explain why other studies failed in identifying variations in hCtr1 transcription levels in 
response to copper stress conditions. 
Further studies will be required to verify if Sp1 can regulate in a coordinate way transcription 
of multiple genes involved in copper homeostasis and in particular Ctr2.  
It will be important to address the mechanism by which Sp1 can sense variations in copper 
levels. 
 
 
 
1.2.3 Ctr1 localization and trafficking 
 
Most of the studies about hCtr1 steady state subcellular localization have been carried out in 
cell cultures, since the earlier works it has been reported that localization is dependent of the 
cell line studied. The protein can be observed either on the cell surface, in a perinuclear 
vesicular compartment, not yet identified, or on both (Klomp et al., 2002; Puig et al., 2002) 
Studies carried out in Hela cells and Chinese Hamster Ovary (CHO) transfected with hCtr1, 
showed that even low extracellular copper concentration triggers a very rapid clearance from 
the plasma membrane through a clathrin-dependent endocytosis. At high extracellular copper 
concentrations hCtr1 degradation was observed as well (Petris et al., 2003). The same group 
later showed that while the conserved MXXXM in the second TMB domain is essential for 
both copper induced endocytosis and degradation, the MMMMPM motif in the extracellular 
domain near to the first TMB mediates endocytosis under low copper concentration (Guo et 
al., 2004). Other groups reported no change in endogenous Ctr1 localization followed by 
copper exposure (Klomp et al., 2002; Eisses et al., 2005a). 
It is conceivable that copper-stimulated endocytosis of hCtr1 only occurs in certain cell types 
and that could also explain the different steady state localization but fewer studies are 
available about Ctr1 localization in vivo.  
A different Ctr1 distribution in duodenal enterocytes was observed in adult compared with 
suckling mice, while the former had pronounced intracellular staining, the latter showed 
predominant apical staining (Kuo et al., 2006). 
Ctr1 has been reported to re-localize on the plasma membrane in mammary gland cells in 
response to sucking and prolactin stimulation (Kelleher and Lönnerdal, 2006). These studies 
suggest that Ctr1 expression is modulate in response to copper status mainly by post-
translational regulation, and in particular trafficking, rather than by transcriptional activation 
or repression. 
 
 
1.2.4 Ctr1 post-translational modifications  
 
Human Ctr1 has two glycosylation sites, both located in the amino terminus side of the 
protein. A N-linked oligosaccharide is added to residue Asn-15 in the consensus sequence 
NX[T/S] but the function of this glycosylation is still unknown, since mutagenesis of this 
residue and loss of the N-linked oligosaccharide does not seem to influence half time, cell 
surface exposure or Cu transport activity  (Klomp et al., 2003; Maryon et al., 2007). The N- 
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Figure 4. Sequence alignments of Ctr1 sequences from different vertebrate species using ClustalW. 
Predicted trasmembrane domains (TMD) are in brown. The putative transmembrane copper binding 
domain (MXXM) is in green, putative N-term and C-term copper binding domains (MXM) are in 
blue, and putative lysosomal sorting signals are in red. N-glycosylation site (NXT) is in orange and O-
glycosylation site (HXTTS) is in cyan. Sequences were downloaded from UniProt (Universal Protein 
Resource www.uniprot.org). 
 
 
 
glycosylation consensus sequence NX[T/S] seems highly conserved in mammals but not in 
other vertebrates (Fig. 4). 
An O-linked oligosaccharide is added to the residue Thr-27, and seems important to proctect 
Ctr1 from proteolytic degradation. Chemical or genetic removal of this oligosaccharide results 
in the production of a cleaved form of hCtr1, of apparent molecular mass 17kDa, lacking of 
approximatively 30 aminoacids from the aminoterminus. This shorter form seems to retain 
about 50% of copper uptake in comparison to the full protein (Maryon et al., 2007). 
It is currently unknown how this proteolytic cleavage is regulated, and if the full and the short 
form of hCtr1 localize to different compartments or have distinct functions. 
The O-glycosylation site is part of an aminoacid array PT[T/]S that seems highly conserved in 
all vertebrate sequences (Fig. 4). 
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1.2.5 Ctr1 role in vertebrate development and physiology 
 
Ctr1 has been shown to be essential for correct development in different vertebrate models. 
Ctr1 null mice die in utero during gestations and present severe development defects (Kuo et 
al., 2001; Lee et al., 2001). 
Knockdown of ctr1 by antisense morpholino oligonucleotides (MOs) causes early lethality in 
Zebrafish larvae, and in tissues where Ctr1 was most heavily expressed, in particular brain 
and spinal cord, an extensive cell death was observed (Mackenzie et al., 2004). 
The similarity in the expression pattern in different vertebrate species could indicate that in 
early embryos Ctr1 is required at high levels in all cells. 
A recent study highlighted the possibility that Ctr1 plays a role in regulation of stem cells 
differentiation and tissue morphogenesis during embryogenesis by physical interaction with 
tyrosine kinase Laloo involved in FGF activation pathway, independently by Ctr1 copper 
transport activity (Haremaki et al., 2007). 
Generation of conditional Ctr1 knockout in intestinal epithelial cells suggested a role for Ctr1 
in dietary copper uptake. Those mice exhibit striking growth defects and a concomitant 
copper deficiency in all peripheral tissues (Nose et al., 2006). The precise localization of 
mouse Ctr1 in intestinal epithelial cells is controversial, since different groups reported either 
apical (Nose et al., 2006; Kuo et al., 2006) or basolateral localization (Zimnika et al., 2007). 
Interestingly the Ctr1 null IECs (Intestinal Epithelial Cells) accumulate high levels of non 
bioavailable copper, probably trapped in intracellular compartment, suggesting a role for Ctr1 
in intracellular copper mobilization more than in mediating Cu uptake from the intestinal 
lumen. Further studies will be required to decipher Ctr1 localization and mechanism of action 
in these cells. 
Conditional hepatic Ctr1 knock out mice show lower copper concentrations in the liver and in 
blood compared to control animals, but do not have a pronounced copper deficiency in other 
tissues and have only mild growth defects (Kim et al., 2009). Interestingly in these transgenic 
mice while biliar copper excretion is reduced, more copper is secret in the urine, suggesting a 
coordinate role for liver and kidney in maintaining copper homeostasis in the body.   
 
 
 
1.2.6 Copper Transporter 2 (Ctr2) 
 
While much is known about the plasma membrane transporters, mediating copper uptake 
from the extracellular environment, very little information is available regarding intracellular 
copper transporters that have structural homology to the plasma membrane Ctr1 proteins.  
Vacuolar copper transporters sharing sequence homology with Ctr family were firstly 
characterized in yeast Saccharomyces cerevisiae (Portnoy et al., 2002) and Saccharomyces 
pombe (Bellemare et al., 2002). In particular the former, designated as Ctr2, was shown to 
function in mobilizing vacuolar intracellular copper stores through a mechanism likely similar 
to that used by Ctr1 for copper import (Rees and Thiele, 2004). 
Following studies in yeast supported the hypothesis that yeast Ctr2, as Ctr1, requires the 
presence of a metalloreductases to work properly, suggesting both proteins transport copper 
across membranes preferentially in the reduced form Cu(I) (Rees and Thiele, 2007). The 
recently identified family of metalloreductases in mammals, renamed STEAP, suggests the 
possibility that the reduction of Cu(II) to Cu(I) mediated by this protein is coordinated with 
Ctr2 activity (Ohgami et al., 2006). 
A Ctr2-like protein, renamed hCtr2 was identified in humans and mice by sequence homology 
with hCtr1 (Zhou and Gitschier, 1997). 
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Figure 5. A) Ctr2 predicted topology based on sequence homology with Ctr1. The putative 
transmembrane copper binding domain (MXXM) is in white, and the putative N-term copper binding 
domain (MXM) is in blue. B) Hydrophobic plot of the mouse Ctr2 sequence highlighting the three 
predicted transmembrane domains. 
 
 
 
No structural and topological data are available for hCtr2, but based on the prediction of the 
TMDs (Fig. 5B) and sequence homology with hCtr1, the N-terminus is predicted to be in the 
vesicular lumen, and the C-terminus and the loop between TMD1 and TMD2 in the 
intracellular side (Fig. 5A).  
While the three TMDs share high homology with hCtr1 and the MXXXM and GXXXG 
motives are fully conserved, the N-terminus and C-terminus of hCtr2 are significantly 
different from hCtr1 (Fig. 6).  
Notably hCtr2 lacks the His- ad Met- rich domains in the N-terminus that in hCtr1 have been 
associated with high affinity copper transport, and the putative copper binding site HCH in 
the C-terminus (De Feo et al., 2009) showed to be important for hCtr1 folding and 
holigomerization (Lee et al., 2007). Furthermore the N- and O-glycosilation sites conserved in 
all the hCtr1 sequence are missing in hCtr2 (Fig. 5) and western blot studies seem to confirm 
that hCtr2 is not glycosilated (van den Berghe et al. 2007, Bertinato et al., 2008). 
van den Berghe et al. (2007) showed that overexpression of hCtr2 in human cells results in 
increase in bioavailable cytosolic copper only in presence of high extracellular copper 
concentrations, with a mechanism dependent of the integrity of the MXXXM motif. 
Bertinato et al. reported similar result showing by kinetics studies that hCtr2 dependent 
increase in cellular total copper content was concentration dependent, saturable and not due to 
a decrease in copper excretion (Bertinato et al., 2008). 
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These studies suggested the hypothesis that hCtr2 mediates low affinity copper import in 
human cells.  
Ctr2 localization remains more elusive, in fact while overexpressed hCtr2 epitope-tagged 
forms clearly co-localize with lysosomal markers (van den Berghe et al., 2007) endogenous 
hCtr2 seems to have a more diffuse perinuclear staining and was partially detected on the 
plasma membrane (Bertinato et al., 2008). It is possible that, as for hCtr1, also hCtr2 
localization is cell specific. 
 
 
 
 
 
Figure 6. Sequence alignments of Ctr2 sequences from different vertebrate species using ClustalW. 
Predicted trasmembrane domains (TMDs) are in brown and indicated by roman numbers. The putative 
transmembrane copper binding domain (MXXM) is in green, putative N-term binding domain (MXM) 
are in blue, putative lysosomal sorting signal [D/E]XXXL[LI] in pink, and putative lysosomal sorting 
signal YXXØ are in red. Sequences were downloaded from UniProt (Universal Protein Resource 
www.uniprot.org). 
 
 
 
1.2.7 Putative lysosomal sorting signals in Ctr1 and Ctr2 vertebrate sequence 
 
Analysis of the vertebrate Ctr1 and Ctr2 sequences revealed the presence of three conserved 
putative YXXØ signals in both proteins and an additional D[E]XXXL[LI] motif in Ctr2 (Fig. 
4 and 6). The position and number of these motives in the Ctr proteins are unusual 
(Bonifacino JS, personal communication), and only mutagenesis of these sequences will 
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allow verifying their putative involvement in either trafficking or degradation of Ctr1 and 
Ctr2 in the lysosomes. 
These motives are conserved throughout the protist and animal kingdoms and in order to be 
active need to be exposed to the solvent being accessible to interactions with the sorting 
machinery. Given their close location to the putative TMDs it is not possible to predict if the 
YXXØ signals are accessible to the sorting machinery, or possibly they become closer only 
after the conformational changes induced by copper binding (De Feo et al., 2009). 
 
1) D[E]XXXL[LI]: these dileucin sorting signals can either participate in internalization and 
degradation of surface receptors when following a serine residues (CD3 and CD4) or 
when constitutively active can contribute to lysosomal-endosomal localization of proteins 
and in the latter case are usually found in the C-terminus (NPC1 and LIMP2). These 
motives are conserved throughout the protist and animal kingdoms. Mutagenesis analysis 
revealed that the substitution of either leucin abrogates the function while the acid 
residues D/E favors lysosomal targeting but is less important for internalization. These 
signals are recognized by AP-1, AP-2 or AP-3 complexes (Bonifacino and Traub, 2003). 
2) YXXØ: these tyrosine based sorting signals are found in a broad range of endocytic 
receptors (Transferrin receptor, cation dependent mannose phophate receptor, LAMP1, 
LAMP 2, among others) that have different intracellular localization but all share the 
property of trafficking to the plasma membrane to some extent. These signals have been 
implicated in several functions such as endocytosis, lysosomal targeting and basolateral 
targeting in polarized cells. Mutagenesis analysis revealed that the tyrosine is essential for 
function and when a glycine precedes the Y residue this motif is involved in lysosomal 
targeting. Usually residues in X positions tend to be acids while the Ø position 
accommodates residues with bulky hydrophobic side chains. Also the distance from 
transmembrane domains (TMD) affect the activity of the tyrosine based signal: purely 
endocytic YXXØ signals are usually found 10-40 residues from TMD and not at the C-
terminus of proteins, while lysosomal targeting signal are located 6-9 residues from TMD 
and usually at the C-terminus of proteins. YXXØ signals have been shown to interact with 
the µ subunits of the four AP complexes, and this interaction may be regulated by 
phosphorylation of the YXXØ signals or adjacent residues (Bonifacino and Traub, 2003). 
 
 
 
 
 
1.2.8 Aims of the research 
 
The goal of the research was to study by immunoblot the expression of endogenous mouse 
Ctr2 (mCtr2) in cell cultures and in mouse models to understand its regulation, and to employ 
siRNA mediated silencing to get insights about its function in copper homeostasis.  
We collected evidences about regulation of mCtr2 protein levels in a copper and Ctr1 
dependent way. Our observations in cells and transgenic mice suggest that lack of Ctr1 
induces a strong downregulation of Ctr2 probably by a post-translational mechanism.  
 The other goal was to inquire its subcellular localization and putative trafficking in response 
to copper status by indirect immunofluorescence. 
We observed an exclusive intracellular localization in a perinuclear intracellular compartment 
and no co-localization with lysosomal markers. 
Furthermore immunofluorescence experiments, supported by sequence analysis, suggest that 
lysosomes may play a role in mCtr2 biology not as resident compartment, but as a 
degradation site.  
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2. Materials and Methods 
 
 
Reagents and antibodies 
 
All chemical reagents were of molecular biology purity level. Anti mouse Ctr2 antibody 
(mCtr2Ab) was raised in rabbits: a synthetic peptide of the sequence H2N-
VSIRYNSMPVPGPNGTILC-CO2H, which corresponds to the 19 aminoacids in the putative 
cytosolic loop between transmembrane domains 1 and 2 of mouse Ctr2 was used as antigen 
for generation and affinity purification of rabbit polyclonal antiserum by Bethyl Laboratories, 
Inc. (Montgomery, TX). 
Anti human Ctr1 antibody (hCtr1Ab) was raised in rabbits: a synthetic peptide of the 
sequence H2N-VSIRYNSMPVPGPNGTILC-CO2H, which corresponds to the cytosolic loop 
between transmembrane domains1 and 2 of mouse and human Ctr1, was used as antigen for 
generation and affinity purification of rabbit polyclonal antiserum by Bethyl Laboratories, 
Inc. (Montgomery, TX). 
Other antibodies used were commercially available: actin (Santa Cruz), GAPDH (Ambion), 
CCS (Santa Cruza), COXIV (Abcam), LAMP1 (eBioscience), RAB7 (Sigma), RAB9 
(ABcam), PDI (Abcam), Cadherin (ABcam), 58k Golgi protein (Abcam).  
 
 
 
Cell cultures 
 
Several murine cell lines were used to study mCtr2 expression and localization: RAG (renal 
adenocarcinoma), Aml12 (normal liver hepatocytes), C2C12 (myoblasts), 3T3 (embryonic 
fibroblasts). E1/E3 (wild type mouse embryonic fibroblast), E7/E8 (Ctr1 knockout embryonic 
fibroblast) were generated as described by Lee et al. (2002). Commercial cell lines were 
cultured in media recommended by ATCC (American Type Culture Collection). E1/E3/E7/E8 
were cultured in Dulbecco's Modified Eagle's medium supplemented with 20% fetal bovine 
serum, 2mM glutamine, nonessential amino acids, 55µM 2-mercaptoethanol, 100 units/ml 
penicillin and streptomycin, 50 mg/liter of uridine and 110 mg/liter of pyruvate. 
 
 
 
Copper exposure and copper chelation experiments 
 
For copper exposure time course experiments RAG cells were incubated in a growth media 
containing copper chloride, CuCl2 (Sigma) at final concentration 50 µM. Cells were harvested 
for protein extraction after 2h, 4h, 8h, 24h and 72h. Fresh media containing copper was 
changed every 24h. A pool of cells at the same confluence of the ones exposed to the copper 
containing media was harvested for protein extraction as a t0. 
For copper chelation experiments E1/E8 cells were incubated in growth media containing 
BCS (Bathocuproine disulphonate) (Sigma) at final concentration 1mM and cells were 
harvested for protein extraction after 24h. A pool of cells grown in BCS free media were 
simultaneously grown and harvested for protein extraction at the same time. 
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RNAi transfection 
 
siRNA (small interfering RNA) oligonucleotides targeting to either coding sequences or 
3’UTR sequences of the mouse Ctr2 mRNA (1: 5’ AAAGTAGCCAATTACCACCtg 3’; 2 
GTATCCAGGTTCCATGGCCtt 3’; 3: TAAAATGACCTAGCTTTGGtt)   and negative 
control siRNA oligonucleotides were designed and purchased from Ambion.  
Cells at 50% confluence were transfected for 48h with INTERFERin (Polyplus Transfection) 
and siRNA oligos at final concentration of 30nM, according to manufacturer instructions. 
For time course experiment non transfected cells, cells transfected with negative control 
siRNA and cells transfected with Ctr2 siRNA were grown simultaneously and harvested at 
the same time points. After transfection fresh media was added to the cells, and it was 
changed every 24h. 
 
 
 
Generation of Ctr1+/- and Ctr1int/int mice  
  
C57BL/6 male and female mice were used as wild types. Generation of Ctr1 heterozygous 
mice was described by Lee et al. (2001). Briefly a targeting vector containing a neomycin 
PGKneo gene expression cassette and 2.0kb and 3.5 kb genomic sequence flanking 
respectively exons 5’ and 3’ of Ctr1 gene was introduced into mouse derived embryonic stem 
(ES) cell line by electroporation. The thymidine kinase (tk) gene and neomycin resistance 
(neo) gene were used to select ES cells in which the targeting construct had integrated into the 
genome. Clones carrying the targeted Ctr1 allele were injected into blastocysts collected from 
C57BL/6 mice following. The Ctr1+/-  mice were generated by crossbreeding between male 
chimeric mice and female C57BL/6mice.  
Generation of intestinal epithelial Ctr1 knockout mice (Ctr1int/int ) was described by Nose et 
al., 2006. Briefly the Ctr1 structural gene was flanked by loxP sites followed by the PGKneo 
gene cassette with an additional loxP site. The targeting vector was used to generate chimeric 
and heterozygous mice as described above. The PGKneo gene was removed by crossbreeding 
with EIIaCre mice, and mice having the desired allele of Ctr1 flanked by loxP (Ctr1flox/flox) 
were obtained. The Ctr1-deleted allele was obtained by crossbreeding with Villin-Cre mice. 
As a control for expression studies were used tissues from Ctr1 floxed mice (Ctr1flox/flox) of 
the same age and sex. 
 
 
 
Tissue samples collection 
 
Tissues (brain, heart, liver, kidney, testis) were dissected after perfusion with phosphate-
buffered saline (pH 7.4; PBS), frozen in liquid nitrogen, and stored at −80°C until use. The 
small intestine was opened along the long axis, washed in ice-cold PBS, soaked in PBS 
containing 1.5mM EDTA and protease inhibitors at 4°C for 10 min with gentle agitation 
(Chen et al., 2003). After incubation the mesenchyme layer was removed, and intestinal 
epithelial cells were washed three times with ice-cold PBS plus protease inhibitors and 
recovered by centrifugation at 200 × g for 7 min. 
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Protein isolation and quantification 
 
Total crude extracts (T) were prepared homogenizing cell pellets or tissues in 5-10 volumes of 
a lysis buffer containing 1% Triton-X 100, 0,1% SDS and 1mM EDTA and protease 
inhibitors in PBS pH 7,4. Homogenates were incubated on ice for 1h, followed by 
centrifugation at 16,000xg for 20min at 4°C, or 100,000xg for 1h at 4°C. The supernatants 
were used as total extracts (T).  
Supernantant (S) and pellet (P) fractions were prepared homogenizing cells and tissues kept in 
ice with a polytron in 10 mM Tris (pH 7,4) homogenization buffer containing 250mM sucrose 
and 2mM EDTA and protease inhibitors (inhibitor cocktail from Roche and PMFS 1mM). 
Homogenates were initially centrifuged at 5000g for 10min and pellet was discarded. 
Supernatants were further centrifuged at 100000g for 1h at 4°C, and second supernatants were 
kept as such (S), while pellets were suspended in cell lysis buffer, incubated on ice for 1h, 
centrifuged at 100,000xg for 30min to remove undissolved debris and the supernatants were 
used as a pellet fraction (P). 
Protein concentrations were measured by the BioRad Protein DC Assay kit (BioRad 
Laboratories, Hercules, CA) with bovine serum albumin (Pierce) as a standard. 
 
 
 
Differential centrifugation 
 
RAG cell pellets were homogenized with a Dounce Homogenizer in 10mM Tris (pH 7,4) 
buffer containing 250mM sucrose, 2mM EDTA and protease inhibitors (inhibitor cocktail 
from Roche and PMFS 1mM). Homogenates were initially centrifuged at 1000g for 5min and 
pellet was discarded to remove nuclei.  
Supernatants were transferred in a new tube and centrifuged at 3,000g for 10min at 4°C. 
Pellets were suspended in cell lysis buffer, incubated on ice for 30min, centrifuged at 
16,000xg for 20min to remove undissolved debris and the supernatants were used as heavy 
mitochondrial fractions.  
Supernatants were transferred in a new tube and centrifuged at 16,000g for 20min at 4°C. 
Pellets were suspended in cell lysis buffer, incubated on ice for 30min, centrifuged at 
16,000xg for 20min to remove undissolved debris and the supernatants were used as light 
mitochondrial fractions.  
Supernatants were transferred in a new tube and centrifuged at 100,000xg for 1h at 4°C. 
Pellets were suspended in cell lysis buffer, incubated on ice for 30min, centrifuged at 
16,000xg for 20min to remove undissolved debris and the supernatants were used as 
microsomal fractions. Last supernatants were kept as such (S). 
 
 
 
Electrophoresis and western blotting  
 
Protein extracts were resuspended in a 4X SDS-PAGE loading buffer for 10min with and 
without boiling at 95°C for 5min before loading into the gel. Isoproteic amounts were loaded 
into SDS polyacrylamide gel electrophoresis (SDS-PAGE) using Criterion Precast gradient 
gels either 8-16% or 10-20% (BioRad). Proteins were transferred from the gel to a PVDF 
membrane (BioRad) using a discontinuous buffer in a semi dry cell. Briefly, filter paper and 
membrane on the anode were soaked in Tris-CAPS buffer plus 15% methanol (60 mM Tris 
base, 40 mM CAPS, 15% MeOH, ph 9.6) while gel and the filter paper on the cathode was 
soaked in and Tris-CAPS plus 0.1% SDS (60 mM Tris base, 40 mM CAPS, 0.1 % SDS, ph 
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9.6). Transfer was performed at constant current 1.5mA per square centimeter of gel (for 
example, 120mA for a small 8 x 10 cm gel). 
The membranes were blocked in 5% (w/v) non-fat dried milk in T-BST (25mM Tris/HCl, pH 
7.4, 137 mM NaCl and 2.7 mM KCl, 0.05% Tween 20), incubated for 1 or 2h with 1:1,000 
primary antibody dilutions, washed 3 times for 5min in TBS-T, incubated 1h with 1:5,000–
1:10,000 HRP-linked secondary antibodies, washed 3 to 4 times for 5min in TBS-T and 
finally for detection the SuperSignal West Pico Chemiluminescent substrate kit (Pierce, 
Rockford, IL) and Denville Blue Bio Films (Denville Scientific, Metuchen, NJ) were used. 
 
 
 
Indirect immunofluorescence microscopy 
 
Cells grown overnight on coverslip were rinsed with ice cold PBS and fixed/permeabilized 
with two different methods. 
In the first cells were fixed with 3.5% (w/v) paraformaldehyde in PBS pH7 for 10min,  
washed with 100mM glycine in PBS pH7, permeabilized with Triton-X 0.1% in PBS pH7 for 
5 min and blocked for 30 min at room temperature with 1% (w/v) non-fat dried milk in PBS 
pH7. 
In the second method cells were fixed with 100% MeOH at -20°C for 5min, and blocked for 
30min at room temperature with 1% (w/v) non-fat dried milk and saponin 0.3% (w/v) in PBS 
pH7. 
Cells were incubated for 2h at room temperature with primary antibody solutions in the 
blocking buffer at final concentration of 1:200 for 2h at room temperature, washed with PBS 
and incubated for 1h at room temperature in the dark with secondary solutions of AlexFluor 
(either 488 or 568) conjugated antibodies (Molecular Probes/Invitrogen) at final concentration 
1:500. 
Coverslips were washed several times in PBS mounted on coverslides using Prolong Antifade 
Kit (Molecular Probes/Invitrogen) and visualized with Axio Imager widefield fluorescence 
microscope (Carl Zeiss). 
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3. Results 
 
 
3.1 Ctr2 expression in mouse cell lines 
 
Initially different mouse cell lines (in particular Tm4, Aml12, C2C12 and RAG) were tested to 
study mouse Ctr2 expression. Among these RAG cell line was selected as model for 
following characterization experiments, since it showed the highest Ctr2 expression levels. In 
particular this cell line was the only one where the putative Ctr2 monomeric form, whose 
apparent molecular weight matched the expected mouse Ctr2 size of 15 kDa, was easily 
detected in crude total extracts (Fig. 1, lane 1).  
 
 
 
Figure 1. Representative western blot of RAG (T), supernatant (S) and pellet (P) protein extracts 
obtained from RAG cell line. The main bands detected with Ctr2Ab are indicated with red arrows. 
Membranes were stripped and reprobed for GAPDH. Molecular masses are indicated in kDa. 
 
 
 
Usually 3 major bands were detected with the mouse Ctr2Ab in protein extracts from mouse 
tissues and mouse cell lines: 
1) A 35kDa band strongly detected in all mouse cell lines and tissues 
2) A 15kDa band, easily detected in total crude extracts of RAG cells, is also detected in 
other cell lines and tissues only in pellet extracts (Fig. 1, lane 3; Fig. 1A, lanes 1-2; Fig. 
1C lanes 7-8) or in crude extracts prepared spinning at 100000g (Fig. 9, lanes 3-7). The 
molecular weight of this protein corresponds to the expected size of the primary 
translation product of mammalian Ctr2. 
3) A 70kDa band not always detected. 
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Other bands, in particular 100kDa and 20kDa were only occasionally detected and their 
intensity was significantly lower than the ones described above. 
Figure 1 shows a representative sub-cellular fractionation experiment using RAG protein 
extracts. After homogenization in a free detergent buffer and centrifugation at 100000g the 
35kDa and the 15kDa bands are almost exclusively detected in the pellet fraction (Fig. 1, lane 
3), containing membrane associated proteins, while the 70kDa is mainly but not exclusively 
observed in the supernatant (Fig. 1, lane 2), containing soluble proteins. Interestingly the 
intensity ratio between the 15kDa and the 35kDa bands is inverted from total to the pellet 
extract (Fig. 1, lanes 1 and 3). Actin, used as control is mainly retained in the supernatant, 
even though a small fraction is detected in the pellet. 
 
 
 
 
Figure 2. Antibody-peptide competition assay. Decreasing amounts (100÷20 µg) of RAG total 
extracts were loaded in triplicate on the same gel, proteins were blotted on a PVDF membrane, and 3 
single identical membranes (A, B and C) were made. Membrane A was probe with a primary solution 
containing only anti-mCtr2 antibody, membrane B and C with primary solutions pre-incubated with 
80M excess respectively of mCtr2 peptide and a hCtr1 peptide. The main bands detected with Ctr2Ab 
are indicated with red arrows. Membranes were stripped and reprobed for actin. Molecular masses are 
indicated in kDa. 
 
 
 
In order to test the specificity of the antibody it was carried out an antibody-peptide 
competition assay. As shown in Figure 2, incubation of the mCtr2Ab with the peptide used as 
immunogen determines a lack of reactivity of the antibody towards the three main bands, 
while it is still possible to see some faint high molecular weight bands (Fig. 2B). In contrast, 
incubation of the Ctr2Ab with the same molar excess of a heterologous peptide, 
corresponding to the C-tail of hCtr1, it doesn’t affect the detection of these proteins (Fig. 2C) 
and the blot is identical to the one obtained using a primary solution containing only the 
antibody (Fig. 2A). Actin used as a control indicates that all three membranes were equally 
loaded. 
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Figure 3. RAG total protein extracts after RNAi time course experiment. RAG cells at the same 
confluence were transfected with either Ctr2 RNAi oligos (lanes 3,6,8 and 11) or a negative control 
(NC) RNAi oligo (lane 2,5,9 and 10).  Cells were harvested and proteins were extracted at 48h, 72h, 
96h and 120h from the beginning of the transfection. For each time point non-transfected (NT) RAG 
cells at the same confluence were harvested and protein extracted. Main bands detected with Ctr2Ab 
are indicated with red arrows. Membrane was stripped and re-probed for GAPDH and Ctr1. Molecular 
masses are indicated in kDa. 
 
 
 
To further test that the proteins recognized by the antibody were actually products of the Ctr2 
gene, RAG cells were transfected with three siRNA oligos targeting either exon number 3 or 
the 3’ UTR of the Ctr2 mRNA. Time course experiments were performed in order to verify 
the RNAi oligos efficiency in silencing the target proteins and also the duration of such effect. 
The combination of the three siRNA oligos induced a very efficient and repeatable 
knockdown of the 15kDa protein with a single transfection. 
The silencing started from 48h after beginning of transfection (Fig. 3, lane 3), and lasted 
almost 5 days, (Fig.3 lane 11), even though at day 4 and 5 (Fig.3 lane 8 and 11) protein levels 
were rising back up towards control levels. No difference in 15kDa levels were observed at 
any time points between untreated cells and cells transfected with negative control RNAi 
oligo (Fig 3., lane 1 and 2; lane 4 and 5; lane 7 and 9).  
The Ctr2 targeting RNAi oligos did not affect at any time point the levels of the 3kDa and 
70kDa proteins, which remained undistinguishable from the untreated and negative control 
cells (Fig. 3). None of the three bands seem to significantly vary during the time course. 
GAPDH shows equal loading in each lane. 
The same membrane blotted with a Ctr1Ab revealed that also the major band detected with 
this antibody, whose apparent molecular weight is 17kDa, was subjected to a knockdown in a 
time dependent manner very similar to the Ctr2 15kDa band (Fig. 5, lanes 3,6,8 and 11). The 
stripping procedure probably did not remove completely the Ctr2Ab off the membrane, and 
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the Ctr1 blot allows verifying that Ctr2 15kDa and the Ctr1 17kDa are two discrete and 
different proteins. 
 
Figure 4. RAG total protein extracts after copper exposure time course. RAG cells were grown in 
MEM media containing 50µM of copper (CuCl2). Cells were harvested and proteins extracted at 
different time points (0, 4h, 8h, 24h, 48h and 72h). Main bands detected with Ctr2Ab are indicated 
with red arrows. Membrane was stripped and re-probed for GAPDH and Ctr1. Molecular masses are 
indicated in kDa. 
 
 
 
The effect of the addition of 50 µM CuCl2 to the RAG cell culture media on Ctr2 protein 
expression was also tested. Extra copper in the media induced a time-dependent down-
regulation of the 15kDa band, starting after 24h (Fig. 4, lane 4) and becoming more intense at 
48h (Fig. 4, lane 5) and 72h (Fig. 4, lane 6), while the 35kDa and the 70kDa levels remained 
unaltered (Fig. 8). 
Probing the same membrane for CCS (Copper Chaperone for SOD1) showed a decrease in the 
expression of this protein upon copper addition, with a time dependency similar to the one 
affecting the Ctr2 15 kDa protein (Fig. 8). GAPDH levels showed an equal loading of all 
samples. 
Even after 72h of exposure to 50 µM CuCl2 RAG cells did not show any morphological sign 
of toxicity. 
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Figure 5. Ctr2 expression in wild type (E1, E3) and Ctr1 null (E7, E8) cell lines. A) Pellet extracts 
from E1, E3, E7 and E8 were probed with mCtr2Ab. Main bands detected with Ctr2 antibody are 
indicated with red arrows. B) The same blot was stripped and re-probed for Ctr1. Main bands detected 
with Ctr1 antibody are indicated with green arrows. Blot was stripped once more and re-probed for 
GAPDH. C) Western blot with total protein extract (T) (lanes 1,2,3) supernatant extracts (S) (lanes 
3,4,5) and pellet extracts (P) (lane 7,8,9) respectively from RAG, E1 and E8 cell lines. Main bands 
detected with Ctr2Ab are indicated with red arrows. Membranes were stripped and re-probed for actin. 
Molecular masses are indicated in kDa. 
 
 
 
It was decided to investigate Ctr2 expression levels in two embryonic cell lines previously 
generated and characterized in the laboratory, called E7 and E8, derived from Ctr1 null mouse 
embryos. As comparison we used two other cell lines, called E3 and E8, derived from wild 
type mouse embryos of the same age. 
Figure 5A shows Ctr2 expression in pellet extract from E1, E3, E7 and E8. The 15kDa band is 
clearly detected in the two wild type cell lines but not in the Ctr1 null derived lines. The 
35kDa is barely visible but is present in all 4 lanes while the 70kDa band was not detected in 
this blot. Re-probing the same membrane for Ctr1 confirmed that all the Ctr1 species 
(monomeric, dimeric and fragment) were detected only in the wild type cells (Fig. 5B). 
GAPDH was used as loading control. 
Figure 5C shows a sub-cellular fractionation experiment carried out in RAG, E1 and E8 cells. 
As previously showed in all three cell lines 35kDa and the 15kDa bands are almost 
exclusively detected in the pellet fraction (Fig 1. lane 3), while the 70 kDa is retained mainly 
but not exclusively in the supernatant. In general E1 and E8 showed a lower expression of the 
15kDa and 35kDa proteins compared to RAG cells. The 35kDa levels are basically identical 
in the two mouse embryonic cell lines, both in total extract (Fig. 5C, lanes 1-3) and pellet 
(Fig. 5C 7-9). Instead, the 15kDa has a markedly reduced expression in the E8 compared to 
E1. Overexposure of this blot was necessary to show that in E8 pellet the 15kDa band is still 
detectable, and therefore its expression is only strongly reduced and not completely 
suppressed (Fig. 5C, lane 9). 70kDa protein levels appear similar in all three cell lines. Blot 
overexposure resulted also in the detection of more bands especially at high molecular weight. 
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As previously shown in all cell lines extracts the intensity ratio between the 15kDa and the 
35kDa bands is inverted from total to pellet extracts (Fig. 5C, lanes 1 and 7, 2 and 8).  
Probing for actin showed an equal loading of the E1 and E8 total, supernatant and pellet 
extracts and lower levels of this protein in the RAG cells compared to E1 and E8. Similar 
results were obtained with E3 and E7 (data not shown). 
 
 
 
Figure 6. Effect of copper chelation on Ctr2 expression in E1 and E8 cells. For both lines controls 
and BCS treated cells were harvested at the same confluence and protein was extracted. Main bands 
detected with Ctr2Ab are indicated with red arrows. Membrane was stripped and re-probed for actin. 
Molecular masses are indicated in kDa. 
 
 
 
The effect of copper chelation in wild type and Ctr1 null cell lines was analyzed after 24 
hours of treatment. The copper chelator BCS (Bathocuproine disulphonate) induced an 
increase in 35kDa protein in both E1 (Fig.6 lane 1 and 2) and E8 (Fig. 6, lane 3 and 4) cells, 
and an increase of the 15kDa protein in E1 cells (Fig. 6, lane 1 and 2). The 15kDa band 
remained undetected in the total extracts of control as of BCS treated E8 cells (Fig. 6, lane 3 
and 4). Probing for GAPDH indicates equal loading. 
Centrifugation experiments in RAG cells were carried out differential in order to get 
information about Ctr2 subcellular localization. Four different protein extracts were generated 
from two different cell pool using sequential and increasing centrifugation speeds: 3000g 
(light mitochondrial fraction), 16000g (heavy mitochondrial fraction), 100000g (microsomal 
fraction) and the supernatant (S) generated from the last centrifugation. 
The result of this experiment, shown in Figure 7, highlights a different centrifugation pattern 
for the two main proteins detected by the Ctr2Ab. The 15kDa band is present at comparable 
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levels in the heavy mithocondrial/3000g (Fig. 7, lane 1 and 2) and microsomal /100000g  
(Fig. 7, lanes 5 and 6) fractions, and it is slightly elevated in the light mitochondrial 
(160000g) fraction. Despite the blot was overexposed the 15kDa it is not detectable in the 
supernatant (Fig. 7, lane 7 and 8). Instead the 35kDa band is mainly retained in the light 
(3000g) and heavy mitochondrial fractions (Fig. 7, lane 1, 2, 3, 4), while it is markedly 
reduced but still detectable in the microsomal fraction (Fig 7, lanes 5 and 6) and in the 
supernatant (Fig. 7, lane 7 and 8). The amount of the 70kDa band seems to decrease from the 
first to the last fraction but is not clearly detected in this blot. 
Among the other protein tested on the same fractions, GAPDH is mainly detected in the 
supernatant, COXIV exclusively in the mitochondrial fractions (mainly in the heavy), while 
the RAB7, a membrane associated protein and LAMP1, an integral membrane protein, 
showed a distribution pattern similar to the 15kDa band, with basically no signal in the 
supernatant. The same blot was also probed for Ctr1, and probably due to the multiple 
stripping and re-probing operations it was possible to clearly detect only the 17kDa band, 
whose distribution pattern was identical to the Ctr2, 15kDa protein (Fig. 7). 
 
 
 
 
Figure 7. Differential centrifugation experiment using cell protein extracts from two different 
RAG cell pools (named R1 and R2). Cells were homogenized in detergent free buffer and the 
resulting homogenate was subjected to sequential centrifugations at increasing speed. After each 
centrifugation the pellet was resuspended in cell lysis buffer and supernatant was used for the 
following centrifugation. Main bands detected with Ctr2Ab are indicated with red arrows. Membrane 
was stripped and re-probed for GAPDH, COXIV, LAMP1, RAB7, and Ctr1. Molecular masses are 
indicated in kDa. 
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Ctr2 expression in mouse tissues 
 
 
We investigated the expression of endogenous Ctr2 in tissues of wild type and transgenic 
mice fed on nutritionally complete diets. 
 
 
Figure 8. Representative western blot of total protein extracts from tissues of two wild type mice. 
Main bands detected with Ctr2Ab are indicated with red arrows. Membrane was stripped and re-
probed for GAPDH and Ctr1. Molecular masses are indicated in kDa. 
 
 
 
In general it was noticed that using the classic 16000g centrifugation speed for crude/total 
protein extract preparation, the 35 kDa band was relatively easy to detect, while it was much 
harder to detect the 15 kDa protein. The representative blot of tissue protein extracts from two 
different male wild type adult mice is shown in Fig. 8. A total protein extract from RAG cells 
was loaded in the gel to verify that the identity of the bands observed in tissues was the same 
of the ones detected in cell lines (Fig. 8, lane 13).  
35 kDa protein expression appeared to be more robust in testis, occasionally in this tissue was 
also possible to detect the 15kDa band, usually after overexposure of the blot (Fig. 8, lanes 11 
and 12). Liver (fig. 8, lanes 5 and 6) and kidney (fig. 8, lanes 7 and 8) also expressed high 
protein levels, even if lower than testis, brain (fig. 8, lanes 1 and 2) and heart  (fig. 8, lanes 3 
and 4) showed lower expression levels, while the muscle did not seem to express it at all (fig. 
8, lanes 9 and 10). The 70 kDa band had a very low intensity in this blot. 
In tissues we detected new bands not found in cell lines, in most cases these bands didn’t have 
a regular and repeatable pattern, with the exception of two strong bands, of apparent 
molecular weight of 36 and 38 kDa expressed mainly in kidney and liver (fig. 8, lanes 5-8). 
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Figure 9. Effect of spinning speed and sample heating on Ctr2 protein detection. One Aml12 
pellet and one liver sample were ressuspended in cell lysis buffer. From each suspension two aliquots 
of the same volume were spun at either 16000g (lanes 1,2,5,6) or 100000g (lanes 3,4,7,8). Isoproteic 
volumes of the resulting supernatant were loaded as such (lanes 1,3,5,7 marked as nb) or boiled for 5 
min at 95°C before loading (lanes 2,4,6,8 marked as b). Main bands detected with Ctr2Ab are 
indicated with red arrows. Membrane was stripped and re-probed for GAPDH, Ctr1 and LAMP1. 
Molecular masses are indicated in kDa. 
 
 
 
Given the results obtained by biochemical fractionation it was decided to test if the 
centrifugation speed after homogenizations of the pellets in the lysis buffer would affect the 
detection of the 15kDa protein. 
To test this hypothesis we carried out a simple experiment: a cellular pellet from Aml12 (Fig. 
9, lanes 1-4) and a piece of liver from a male adult mouse (Fig. 9, lanes 5-8) were 
homogenized in cell lysis buffer and splitted in 2 aliquots of equal volume. One aliquot was 
spun 16kg and the other at 100kg. The resulting supernatants were loaded on the gel in 
isoproteic amounts. 
We found that in supernatants (either from cell or tissue) prepared spinning the homogenates 
at 100000g the detection of the 15kDa band by immunoblot resulted significantly enhanced, 
while the increased speed had no effect on the detection of 35kDa band (Fig. 9, lanes 3 and 7).  
In the same experiment Ctr1 17kDa fragment detection was improved in a similar but less 
marked way, while LAMP1 detection, found only in liver extracts (Fig. 9, lanes 3 and 7), was 
not affected by the spinning speed.  
Furthermore boiling the samples prior to loading on the gel resulted in strong decrease in the 
intensity of the Ctr2 15kDa (Fig. 9, lanes 3-4 and 7-8), Ctr1 fragment (Fig. 9, lanes 1-2, 3-4, 
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5-6 and 7-8) and LAMP1 (Fig. 9, 5-6 and 7-8), but had no effect on the detection of Ctr2 
35kDa band. 
For the following experiments a 100000g spinning speed was employed in the preparation of 
total protein extracts from tissues. 
 
 
 
Figure 10. Ctr2 expression in brain (B), heart (H), intestine (I), kidney (K) and liver (L) of one 
control (Ctr1+/+) and one heterozygous Ctr1 (Ctr1+/-) adult mouse. Main bands detected with 
Ctr2Ab are indicated with red arrows. Membrane was stripped and re-probed for GAPDH. Molecular 
masses are indicated in kDa. 
 
 
 
Then Ctr2 levels were tested in transgenic mice carrying only one copy of the CTR1 gene 
(Ctr1+/- heterozygous). Figure 10 shows a representative blot containing total protein extracts 
from different tissues of one adult wild type (Ctr1+/+) mouse (Fig. 10, odd lanes) and one Ctr1 
heterozygous (Ctr1+/-) mouse, both female and of the same age. We observed in several 
samples that Ctr2 15kDa expression in the liver was significantly lower in Ctr1+/-  (Fig. 10, 
lane 10) compared to Ctr1+/+ (Fig. 10, lane 9). In this blot also the 70kDa seems to be 
regulated in a similar way. 
Ctr2 15kDa was detected at low intensity in intestine and kidney (Fig. 9, lanes 5,7 and 8) but 
not in brain and heart, where high molecular bands were observed for both genotypes (Fig. 9, 
lanes 1-4). 
GAPDH was used as loading control between same tissues: the intestinal sample from the 
heterozygous mouse was either underloaded or degraded (Fig. 9, lanes 1-4). 
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Figure 11. Ctr2 expression in control (flox) and intestinal conditional Ctr1 knockout mice (int). 
A) Ctr2 expression in intestinal epithelial cells (IEC), heart (H), and brain (B) of one control (flox) and 
in one intestinal conditional Ctr1 knockout (int) mouse. Ctr2 expression in liver (L) and kidney (K) of 
two control (flox) and two intestinal Ctr1 knockout (int) mice. Main bands detected with Ctr2Ab are 
indicated with red arrows. Membrane was stripped and re-probed for GAPDH. B) Ctr2 expression in 
intestinal epithelial cells (IEC) in one control (flox) and one intestinal conditional Ctr1 knockout (int) 
mouse. Main bands detected with Ctr2Ab are indicated with red arrows. Membrane was stripped and 
re-probed for actin, GAPDH and Ctr1. All molecular masses are indicated in kDa. 
 
 
 
Ctr2 expression was analyzed in a mouse model for copper deficiency, the Ctr1 intestinal 
conditional knockout (Ctr1int/int), in which only epithelial cells were lacking of Ctr1, while all 
the other peripheral tissues were homozygous for Ctr1 but copper deficient. Given the 
difficulty in generating such mice only two specimens were studied and were compared with 
control (Ctr1flox/flox) mice of the same age. 
All the bands detected by the mCtr2Ab showed higher expression levels in heart liver and 
brain of transgenic mice than in control animals (Fig. 11A, lanes 3-8, 13-14). 
The 15kDa Ctr2 protein is significantly more expressed in kidneys of conditional Ctr1 
knockout mice than control animals (Fig. 11A, lanes 9-10, and 11-12). 
In contrast in the intestinal epithelial cells (IEC) of the Ctr1int/int mouse the 35kDa band seems 
to be downregulated when compared to the Ctr1flox/flox, while the 15kDa band is basically not 
detectable in the Ctr1 null cells (Fig. 11A, lane 2; Fig. 11B, lane 2). Two different samples of 
intestinal epithelial cells collected from Ctr1flox/flox and Ctr1int/int were probed for Ctr2 
expression, and a very similar result was obtained as shown in Fig 11B.  
GAPDH and actin were used as loading controls and Ctr1 was used to confirm the identity 
and the genotype of the samples. 
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Ctr2 cellular localization  
 
 
Initially different cell lines were screened as a model for immunolocalization experiments. 
Among these 3T3 was chosen because of its favorable morphological features, in particular 
the flat shape and the abundance of cytoplasm, which make them an excellent model for 
immunofluorescence experiments. 
Cells were fixed with 3% paraformaldehyde and permeabilized with Triton-X 0.1%. 
In comparison experiments, light intensity and contrast were adjusted to the same level. 
 
 
 
 
Figure 12.  Indirect immunofluorescence analysis of an antibody competitionm assay. After the 
same fixation, permeabilization and blocking 3T3 cells were stained with different primary antibody 
solutions. A) Containing only Ctr2Ab. B) Containing Ctr2Ab and 80 molar excess of the homologous 
peptide. C) Containing Ctr2Ab and 80uM excess of a heterologous peptide. All cells were then labeled 
with AlexaFLuor 488 conjugated donkey anti-rabbit antibodies, and analyzed under the microscope.  
 
 
 
An antibody-peptide competition assay was carried out to test specificity of the antibody, 
similar to what was previously done by immunoblot. As shown if Fig.12 pre-incubation of the 
mCtr2Ab with the peptide used as immunogen almost completely abolishes the staining (Fig. 
12B). In contrast pre-incubation of the mCtr2 antibody with the same molar excess of a 
heterologous peptide, corresponding to Ctr1 C-tail sequence, doesn’t affect the 
immunostaining (Fig. 12C). 
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Figure 13. Analysis of 3T3 cells fixed with methanol at -20C and permeabilized with saponin. A 
and B) Cells labeled with Ctr2Ab followed by AlexaFLuor 488 conjugated donkey anti-rabbit 
antibodies. C and D) Cells labeled with Ctr1 antibody and with AlexaFLuor 488 conjugated donkey 
anti-rabbit antibodies. E-F) Cells were simultaneously labeled with Ctr2Ab followed by AlexaFLuor 
488 conjugated donkey anti-rabbit antibody and CadherinAb followed by AlexaFLuor 568 conjugated 
goat anti-mouse antibody and G) Overlay.  
 
 
 
During screening of different cell lines it was never observed plasma membrane staining with 
Ctr2 antibody. During such screening we tried to label cells with the Ctr1 antibody, but we 
failed to detect staining on the plasma membrane either. To rule out the possibility that the 
lack of plasma membrane signal was due to the fixation/permeabilization protocol it was used 
an alternative method applying ice-cold methanol for fixation and saponin 0.3% for 
permeabilization. Using such protocol we were able to detect plasma membrane staining with 
Ctr1 antibody (Fig.13B) but not with Ctr2 antibody (Fig. 13A). Figure 13G shows that while 
staining for Ctr2 is exclusively intracellular (green), staining for cadherin is mainly on the 
plasma membrane (red). 
The yellow area in the figure is probably due to bleeding-through of the signal from the red 
channel into the green channel due to the strong intensity. 
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Figure 14. Analysis of 3T3 cells stained for Ctr2 and lysosomal markers. Cells were 
simultaneously labeled with Ctr2Ab (A), LAMP1 antibody (B) and (C) overlay. D) Overlay of green 
and red channels after staining with Lysotracker red and LAMP1Ab. E) Overlay of green and red 
channels after staining with Lysotracker red and Ctr2Ab. 
 
 
 
Putative lysosomal localization was studied using two different markers: LAMP1 (lysosomal 
associated protein 1), one of the most abundant proteins found on the lysosomal membranes, 
and Lysotracker red (Invitrogen), a fluorescent dye that specifically labels vesicles/granules 
belonging to the lysosomal system. Ctr2Ab staining did not co-localize neither with LAMP1 
(Fig 14C) nor with lysotracker (Fig. 14E) staining. 
LAMP1 and lysotracker when used simultaneously resulted in a high degree of co-
localization in large vesicles/granules, highlighted in yellow in Fig. 14D. 
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Figure 15. Analysis of 3T3 stained for Ctr2 and markers for the major subcellular 
compartments. A-B-C) 58kDa (Golgi). D-E-F) COXIV (Mitochondria) G-H-I) Mitotracker 
(Mitochondria) J-K-L) Transferrin Receptor 1 (recycling endosomes) M-N-O) RAB9 (late 
endosomes).  
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We also tested several markers for the major intracellular compartments: endoplasmatic 
reticulum PDI (data not shown), mitochondrial COXIV (Fig. 15E) and Mitotracker Red (Fig. 
15H), 58kDa Golgi protein (Fig. 15B), mitochondrial COXIV (Fig. 15E), Mitotracker Red 
(Fig. 15H) and recycling endosomal TfR1 (Fig. 15K). Ctr2 staining (respectively FIG.15A-D-
G-J-M) did not co-localize with any of these markers (Fig. 15C-F-I-L-O). 
Only the RAB9 (Fig. 15N) staining partially co-localized with Ctr2 (Fig.15 M) as shown if 
Fig. 15O, yellow areas.  
Finally we tested if copper supplementation or chelation in the growth media of E1 and E8 
cells, could alter Ctr2 localization. Overnight copper starvation or excess did not alter Ctr2Ab 
staining pattern (data not shown). While the overall signal was very similar in both embryonic 
cell lines, in E8 cells we repeatedly observed a characteristic Ctr2 staining in granule-like 
structures (Fig. 16A), that strongly co-localized with LAMP1 (Fig. 16B), as shown in pictures 
16C-D-E-F. 
 
 
 
 
Figure 16. Analysis of E8 stained for Ctr2 and lysosomal marker LAMP1. Cells were 
simultaneously labeled with: A) Ctr2Ab followed by AlexaFLuor 488 conjugated donkey anti-rabbit 
antibody, B) LAMP1 antibody followed by AlexaFluor 568 conjugated goat anti-mouse antibody, C) 
Overlay of green and red channel, D-E-F) Higher magnifications of C, arrows in cyan highlight 
structures co-stained by both antibodies, in yellow. 
 
 
 
 
 
 
 
 35 
4. Discussion and Conclusions 
 
 
In the last decade many proteins involved in copper homeostasis have been identified, and 
particular interested has been focused on the high affinity copper transporters belonging to the 
Ctr family, whose members share sequence homology and likely structural and functional 
features (Dumay et al, 2006). 
In mammals only two different members of this family have been identified, renamed Ctr1 
and Ctr2 (Zhou and Gitschier, 1997). While the former has been extensively studied and 
many progresses have been made in understanding its cellular and physiological role, very 
little is known about the latter (Kim et al., 2008). 
Very recently the structure of human Ctr1 has been resolved, confirming the hypothesis that 
this protein exists on the cellular membranes as homotrimer. Three identical subunits 
spanning the membrane layer three times, with intracellular C-term and extracellular N-term, 
assemble tail-to tail forming a pore-like channel at the center of the trimer (Allen and Unger, 
2006; De Feo et al., 2009).  
Generally in western blot experiments performed under denaturing conditions bands of 
different molecular weight have been detected using antibodies either to detect epitope-tagged 
chimeric (Lee et al., 2002a) or endogenous (Klomp at al., 2002) Ctr1 proteins. Such bands 
have been regarded by the experts in the field as monomeric and multimeric forms of Ctr1, 
despite their molecular weight is often variable and seems to be dependent on the biological 
sample and extraction conditions. 
During this research with the anti Ctr1Ab developed in Dr. Thiele’s laboratory, at Duke 
University, in cell lines and tissues we detected mainly and reproducibly a band of 17kDa 
apparent molecular weight. Recently a similar protein has been shown to be a cleaved version 
of the full Ctr1, produced in case of lacking of the O-glycosylation site at the Thr-27. Such 
proteolytic cleaved version of hCtr1 retains the ability to form dimers, is localized on the 
plasma membrane and promotes copper transport with halved rate compared to the full 
version (Marion et al., 2007).  It is currently unknown if this proteolytic form differs from the 
full version in function, trafficking or signaling and plays a specific role in copper 
homeostasis. 
Especially in cell lines, we often detected a smear around 35 kDa by immunoblitting with the 
hCtr1Ab. Detailed characterization studies carried out in human cell cultures revealed that the 
spaced smear of bands around 33-35 kDa mainly detected with different anti-Ctr1 antibodies, 
corresponds to the full length hCtr1 N-glycosylated at the Asp-15 and O-glycosylated at Thr-
27 (Klomp et al., 2002; Eisses and Kaplan 2005b; Maryon et al., 2007). 
Usually in tissues, the western blot pattern observed with different Ctr1 antibodies is more 
complex, and high molecular weight proteins, usually not found in cell lines, were detected 
(Kuo et al., 2006; Nose et al., 2006; Kim et al., 2008). Currently it is unknown if these 
multimeric forms represent physiological structures or are simply molecular artifacts due to 
aggregation during the extraction procedure. 
No structural data are available yet for Ctr2, but given the partial structural homology with 
Ctr1 it is generally assumed that also Ctr2 may form multimers and possibly homotrimers. 
Recently the Klomp group showed by co-immunoprecipitation experiments that human Ctr2 
might interact with itself and possibly form multimeric complexes. However in such 
immunoprecipitation experiments from cells overexpressing Ctr2 constructs they observed 
only bands corresponding to the monomeric form (around 16 kDa) while bands of higher 
molecular weight were detected only upon chemical crosslinking (va den Berghe et al, 2007). 
Bertinato et al. (2008) developed a human Ctr2Ab, which detected putative monomeric and 
dimeric forms when human Ctr2 was overexpressed as GFP-fused construct in cell lines. Only 
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a single protein of 70kDa was observed in cell lines and rat tissues only, argued to be a 
multimeric complex of endogenous human Ctr2 (Bertinato et al., 2008). Notably no 
endogenous monomeric form was detected. The difference in SDS-gel migration patterns due 
to epitope-tagging or over-expression is not currently understood, however Rees et al. 
reported that a yeast Ctr2 antibody detected by immunoblot mainly an endogenous Ctr2 
protein corresponding to the monomeric form, while dimeric and trimeric complexes were 
observed when yeast Ctr2 was overexpressed by a plasmid (Rees and Thiele, 2007).  
It is important to keep in mind that while mammalian Ctr1 and Ctr2 share high degree of 
sequence identity and similarity, mainly concentrated in the three transmembrane domains, 
their C-tail and N-term domain are quite different. Klomp group showed by yeast two-hybrid 
system how the N-terminal of Ctr1 interacts with itself, and how the methionine rich motif is 
important for such interaction. On the other hand the N-terminal of hCtr2 lacks this motif and 
indeed it does not interact with itself (Klomp et al., 2003). Recent works where hCtr1 
oligomerization was studied by western blot experiments and structural analysis coupled to 
mutagenesis, suggested that detection of bands corresponding to Ctr1 dimeric forms are 
possibly related to inter molecular disulfide bridge formation, involving Cys-161 and Cys-189 
in the C-terminal domain (Eisses and Kaplan, 2005b; Aller and Unger, 2006; Lee et al., 2007; 
De Feo et al., 2009). Ctr2 instead lacks these two cysteins. 
Therefore structural and mutagenesis studies will be necessary to reveal the putative 
holigomerization mechanism allowing Ctr2 multimerization and which aminoacids are 
important in this process. 
The mCtr2Ab developed in Dr. Thiele’s laboratory was able to detect 3 main endogenous 
proteins in western blot experiments, respectively around 15, 35 and 70kDa.  
Three different lines of evidence support the hypothesis that the 15 kDa represents the 
monomeric form of mouse Ctr2: 
1) Its molecular weight matches the one expected from the coding sequence of the mCtr2 
gene. 
2) Overexpression of hCtr2 tagged constructs in different human cell lines resulted in the 
detection of a similar band in western blotting. The main and most notable difference is 
that we were able to detect the endogenous protein not only in all cell lines but also in 
mouse tissues, although to accomplish this goal a modification of the protein extraction 
protocol was required. 
3) RNAi oligonucleotides targeting the mouse Ctr2 mRNA caused a marked and time 
dependent decrease of its expression 
 
The 35kDa, based on the apparent molecular weight may represent a dimeric form, and could 
correspond to one of the multimers detected upon chemical crosslinking by van der Berghe et 
al. The 70kDa band could be the same multimeric form detected by Bertinato et al. in rat 
tissues. The expression of these proteins did not alter following RNAi knockdown of the Ctr2 
gene. It is not possible to rule out the possibility that such bands may represent multimeric 
and very stable molecular complexes with a very long hemi-life. This might be in accordance 
with the fact that Bertinato et al. (2008) were able to obtain a partial silencing of the 70kDa 
band only after 96 hours and a double RNAi transfection using siRNA duplexes targeting 
human Ctr2 mRNA. This hypothesis hardly explains how after a very robust silencing of the 
monomeric form from 48 almost until 120h, the expression of the putative multimeric form is 
not affected at all either. Interestingly the three bands show also different and peculiar 
biochemical properties. 
Interestingly the three bands show different and unusual biochemical properties. While the 15 
and the 35kDa bands are associated with a pelletable fraction the 70kDa band is mainly, but 
not exclusively, associated with the soluble fraction after homogenization in a free detergent 
buffer and centrifugation at 100,000g.  
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Furthermore the 15kDa and the 35kDa bands show different enrichment patterns in fraction 
obtained after differential centrifugation, and while the former is sensitive to heat treatment, 
like most of the membrane associated proteins, the latter is not. It is known that boiling has a 
counterproductive effect on the detection of membrane proteins indeed Ctr1 and Lamp1 show 
heat sensitivity like the 15kDa protein. Instead, the 35kDa protein, despite its association with 
the pelletable fraction that suggests association with biological membranes, seems to be an 
exception to this rule. 
Failure in detecting the 15kDa band by immunoblot probably explains why Bertinato et al., 
were not able to detect hCtr2 momoner, since they boiled samples prior to loading onto SDS-
PAGE (Bertinato et al., 2008).  
According to our immunoblot experiments both 15 and 35kDa bands were more abundant in 
testis, liver, kidney, and less expressed in heart and brain in accordance to the transcription 
levels previously reported in the mouse (Lee et al., 2000) and the hCtr2 protein levels with the 
exception of the heart, where hCtr2 was reported to be highly expressed (Bertinato et al., 
2008). As for Ctr1, in all tissues analyzed and in particular liver and kidney several new 
bands, not observed in cell lines, were detected. Interestingly liver and kidney are also the 
tissues where Ctr1 is highly expressed, even if it’s known that Ctr1 levels vary according to 
age and copper availability (Kuo et al., 2006). 
The 15kDa and 35kDa bands not only show different biochemical properties but also a 
different expression in relation to copper and Ctr1 levels. It is still debated how Ctr1 is 
regulated following copper exposure. Some works reported how elevated extracellular copper 
levels resulted in a rapid internalization from plasma membrane and subsequent degradation 
of hCtr1, with a mechanism involving the C-terminal Methionine-rich domain (Petris et al., 
2003; Guo et al., 2004), similarly to what reported for yeast Ctr1 (Ooi et al., 1996; Liu et al., 
2007).  
Other authors reported no changes in Ctr1 levels or localization following copper exposure 
(Klomp et al., 2002; Eisses et al., 2005a). It is likely that such differences might reflect cell or 
tissue specific regulation. 
Addition of copper to growth media slowly reduced in time dependent manner the 
expressions of 15kDa proteins in RAG cells. The decrease in Ctr2 levels started after 24h of 
copper exposure and became significant only after 48h. Notably the time and copper 
dependent Ctr2 downregulation takes place in parallel with a decrease in CCS levels. CCS is a 
cytosolic copper chaperone that delivers copper ions to CuZn SOD1 (Culotta et al., 1997) and 
has been shown to be regulated by a copper induced degradation, and for this reason it was 
proposed as a biomarker for cytosolic copper bioavailability (Bertinato and L’Abbe, 2003). 
Based on this result it is possible to hypothesize that prolonged exposure to copper leads not 
only to a degradation of CCS but also of Ctr2.  
If mammalian Ctr2, as its yeast hortologue, transports copper from an intracellular 
compartment to the cytosol, it would make sense for the cells to coordinate downregulation of 
Ctr1 and Ctr2 in case of high levels of copper in the extracelluar environment. This regulation 
would be necessary in order to prevent accumulation of high and toxic metal concentrations in 
the cytosol. 
We did not observe any re-localization of endogenous Ctr2 following 24h copper exposure 
(data not shown) as previously reported for an overexpressed tagged version (van den Berghe 
et al., 2007), but this might be due to the short exposure time. 
The most interesting and unexpected difference that further marks the difference between the 
15kDa and 35kDa protein expression, is what appears to be a Ctr1 dependent regulation. 
Two distinct mice Ctr1 knock out cell lines, derived from embryos of Ctr1 knock out mice 
have been described. Those cell lines are viable despite lack of Ctr1 and have been shown to 
possess a low affinity Ctr1-independent copper import system (Lee et al., 2002b). We 
expected that in cells the chronicle copper starvation could induce expression of Ctr2 as 
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compensatory mechanism. Surprisingly we found that in those cells the expression level of 
the 15kDa band is strongly and permanently downregulated, but not completely abrogated. 
On the other hand the 35 and 70kDa proteins levels are not affected by the absence of Ctr1. 
To assess if the Ctr1 dependent downregulation was induced by copper starvation we studied 
Ctr2 expression in copper starved and repleted E1 (WT) and E8 (Ctr1-/-) cell lines. Twenty 
four hours of exposure to copper chelator BCS induced in both cell lines an increase in 35kDa 
band, as well as a significative increase in 15kDa expression in wild type cell lines. Instead in 
Ctr1 null cell lines the 15kDa protein downregulation is not reversible neither following 
copper starvation.  
To assess if this downregulation was due to the physical lacking of Ctr1 or to the chronicle 
copper starvation that affects Ctr1 null cells we investigated Ctr2 expression in Villin-CRE 
intestinal conditional Ctr1 knock out mice. These mice were generated in Dr. Thiele’s 
laboratory by breeding Ctr1 flox mice with mice expressing the CRE recombinase under the 
control of a villin-promoter, which is actively expressed only in intestinal epithelial cells. As 
result the Villin-CRE intestinal conditional Ctr1 express Ctr1 in all tissues but intestinal 
epithelial cells (IEC). Biochemical characterization of those animals highlighted the role of 
Ctr1 in diet copper absorption, since deletion of Ctr1 in IEC cells causes peripheral copper 
depletion in basically all tissues and severe growth impairment. 
We reasoned that given the simultaneous presence of cells lacking of Ctr1 and copper 
deficient cells in the same organism, these mice could be the perfect model to study in vivo 
the Ctr1-dependent Ctr2 regulation. Despite more samples need to be examined our 
preliminary results seem to confirm the hypothesis that the physical lack of Ctr1 induces 
monomeric Ctr2 downregulation, while in copper starved tissues its expression is unaltered, 
or, like in kidney, upregulated. Since kidney was shown to be the tissue were copper 
deficiency was less severe in these mice, it is tempting to speculate that upregulation of Ctr2 
and possibly Ctr1 may counteract low copper concentrations in the blood.  
van den Berghe et al. (2007) speculated that hCtr2 mediates copper uptake in Ctr1 null cell 
lines and IEC, mobilizing lysosomal copper stores uptaken by endocytosis. Based on their 
data hCtr1 works as a high affinity transporter, while hCtr2 copper uptake works with low 
affinity and requires either high concentration of extracellular copper or prolonged exposure 
in order to provide significant copper levels to the cytosol. According to their model the Ctr2 
low affinity copper uptake would explain why the Ctr1 conditional intestinal knockout mice 
still suffer of sever copper deficiency (van den Berghe et al., 2007). Bertinato et al. (2008) 
proposed a similar model where Ctr2 functions as low affinity plasma membrane transporter 
alternative to Ctr1. They also speculate according to this model that Ctr2 may compensate 
loss of Ctr1 in tissues of heterozygous mice, or could replace Ctr1 mediated copper import 
when extracellular copper levels are elevated enough to induce Ctr1 internalization (Bertinato 
et al., 2008). Our experiments indicating that Ctr2 monomer expression is actually almost 
completely abrogated in Ctr1 null cells and partially downregulated in liver of Ctr1 
heterozygous mice, and prolonged exposure decrease its expression as well, would suggest 
that these hypothesis are unlikely.  
The identity of the 35 kDa protein remains enigmatic.  
Despite the RNAi results, the biochemical features and the apparent lack of copper/Ctr1 
dependent regulation two lines of evidence suggest that the possibility of the 35kDa band 
recognized by the mCtr2Ab being a non-Ctr2 related specific protein is unlikely. First, despite 
the fact that the peptide used as immunogen has a unique sequence in the mouse proteome 
and the antibody was isolated by affinity purification the antibody seems to bind the 35kDa 
protein with an affinity similar or superior to the one for Ctr2 monomeric protein. Second, its 
relative expression levels in different cell lines and tissues match the expression levels of Ctr2 
monomeric form. 
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From the results here reported three main hypotheses about the nature of 35kDa protein can 
be formulated:  
1) This protein could be the product of an alternative Ctr2 transcript, not harboring the 
nucleotidic sequence targeted by the RNAi oligos used in knockdown experiments and 
differently regulated by either copper or Ctr1. Interestingly in yeast at least three different 
Ctr2 transcripts carrying different 3’ UTR regions were identified, and one of them seems 
to confer a copper resistant phenotype (Kim Guisbert et al., 2007). In the mouse database 
genome at least three different Ctr2 transcripts are annotated but the fact that all of them 
contain the same coding sequence would not explain the different migration and 
biochemical properties of 15kDa and 35kDa proteins. Notably northern blot analysis in rat 
tissues revealed the existence of two discrete Ctr1 transcripts (Lee et al., 2000). 
2) The mouse genome may code for a Ctr2 pseudogene, not yet annotated in the databases. 
Interestingly Møller and colleagues identified a hCtr1 pseudogene mapping on a different 
chromosome, transcriptionally active, but not inducing a copper phenotype when 
transfected in human cells (Møller et al., 2000). This hypothesis, although unlikely, could 
explain the different biochemical properties and regulation. 
3) It is possible that under conditions used for protein isolation Ctr2 may form SDS-resistant 
and heat resistant aggregates as reported for other membrane proteins (Kubista et al., 
2004). SDS resistant multimeric complex caused by oxidation of cysteins residues and 
inter molecular disulfide bridge formation have been described also for soluble proteins 
the most notable of which is metallothionein (Haase and Maret, 2008). Ctr2 lacks cysteine 
residues and protein aggregation could be caused by to oxidation of methionine residues. 
In alternative the highly hydrophobic nature of its aminoacidic sequence may not allow a 
complete denaturation mediated by SDS, resulting in a non linear migration patterns and 
appearance of high molecular weight bands. In either case apparently constant levels 
under conditions where the Ctr2 monomer expression is radically altered could be 
explained by the high affinity of these putative complexes for the PDVF membrane used 
in western blotting. In this case even very low amount of complexes in the protein extracts 
could easily bind to the membranes leading to a strong signal. This hypothesis could 
explain both the different biochemical properties and the apparent different regulation of 
the 15kDa and 35kDa proteins. 
 
Given the contradictive results for the two main proteins detected by the mCtr2Ab only 
analysis of tissues and cells from Ctr2 knock out mice or in alternative mass fingerprinting, 
will allow to determine if this protein is a multimeric form of mouse Ctr2 or the product of a 
different gene.  
Another goal of this research was to identify the cellular localization of endogenous mouse 
Ctr2. While the yeast hortologue has been localized to the vacuolar membrane mammalian 
Ctr2 localization is still controversial. To accomplish this goal we tested different mouse cell 
lines by indirect immunofluorescence experiments. In all cell lines we always detected a 
perinuclear punctate signal, which we were not able to clearly co-localize with any of the 
markers for the main subcellar compartments.  
van den Berghe et al. (2007) showed that in several cell lines the overexpression of different 
hCtr2 tagged constructs localized in same large vesicles. Such vesicles also contained 
lysosomal markers LAMP1 and LAMP2. Given this result and the biological analogies 
between yeast vacuole and mammalian lysosomes they proposed that hCtr2 localizes in the 
lysosomal membranes. In order to verify this hypothesis we tested mCtr2Ab with two 
different markers, Lysotracker (Molecular Probes) a lysosomal specific dye, and LAMP1, one 
of the most abundant proteins in the lysosomes. Both markers stained mainly large 
vesicles/granules typical of the mature lysosomal compartment, similar to the ones reported 
by van den Berghe and colleagues. Furthermore when used simultaneously they had a high 
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degree of co-localization in such structures. The morphology of the typical intracellular 
staining typical mCtr2Ab was different from the one described above, and indeed neither 
Lysotracker nor LAMP1 staining co-localized with the Ctr2 signal. Bertinato and colleagues 
studied in parallel localization of endogenous and epitope tagged overexpressed hCtr2. 
Interestingly while a GFP-tagged construct strongly localized in large cytoplasmic vesicles, 
similarly to what previously reported by the other group, the staining pattern detected by the 
antibody was completely different, punctuate and perinuclear, similar to what we observed. 
Unfortunately they did not further investigate the identity of such compartment (Bertinato et 
al., 2008). 
The simultaneous overexpression of hCtr1 and hCtr2 constructs harboring different epitope-
tags in human cells resulted in a partial co-localization of the two Ctr members in intracellular 
vesicles (van den Berghe et al., 2007). Given the strong co-localization of the hCtr2 construct 
with lysosomal markers, this experiment would suggest at least a partial localization of hCtr1 
in lysosomes, but this result is in contrast with the literature.  
In fact previous studies revealed that endogenous Ctr1 can recycle and traffic between the 
plasma membrane and small intracellular vesicles, and its main steady-state localization was 
probably dependent on the cell line studied (Klomp et al 2002; Lee et al., 2002a; Eissen and 
Kaplan, 2005a). While the identity of this intracellular compartment remains elusive a 
previous studies from the same group suggested the small vesicles partially co-localizing with 
TGN (Trans Golgi Network) markers but not with lysosomal markers (Klomp et al, 2002; 
Komp et al., 2003). Notably also the ATPase copper transporter ATP7a and ATP7b normally 
reside on the TGN and can traffic and re-localize to the plasma membrane after copper 
exposure (La Fontaine and Mercer, 2007). 
Other groups reported a partial localization of Ctr1 in recycling endosomes containing 
Transferrin Receptor 1 (Petris et al., 2003; Kelleher and Lönnerdal 2006). 
In our experiments we did not observe co-staining of mCtr2Ab neither with TfR1 nor 58kDa, 
a Golgi marker, but we found a partial co-localization with RAB9, a GTPase involved in 
vesicle retrograde transport from the endosomal compartment to the Trans Golgi Network 
(Lombardi et al., 1993; Bonifacino and Rojas, 2006). 
If this localization will be confirmed it would be possible to hypothesize that endogenous Ctr2 
resides at steady state levels in a part of the Trans-Golgi network, possibly at the interface 
with the endosomal compartment, highlighting the possibility that all four major mammalian 
membrane copper transporters might traffic to the same compartment. A copper fluorescent 
dye, named copper sensor 1 (CS1), allowing detection of free copper pools in living cells was 
developed by Zeng et al. (2006). Interestingly such copper pools seem to be contained in 
vesicle-like structures that partially co-localize with fluorescent dyes specific for the Trans 
Golgi Network (Dr Chang CJ, personal communication). Together these observations would 
suggest the intriguing possibility of the existence of copper specialized vesicles in a 
subcellular compartment belonging to the Trans Golgi Network. Without stronger evidences 
such hypothesis remains just a speculation. 
It was not possible for us to test via indirect immuofluorescence the intriguing hypothesis of a 
partial co-localization between endogenous Ctr1 and Ctr2, only indirectly suggested by 
differential centrifugation experiments, because both antibodies were raised in the rabbit. 
Bertinato and colleagues detected a low intensity staining on the plasma membrane using the 
hCtr2 antibody, suggesting a partial localization on the cell surface, despite the epitope-tagged 
form does not seem to stain the plasma membrane (Bertinato et al., 2008) as previously 
reported by the Klomp group (van den Berghe et al., 2007). The cell surface result was 
confirmed by biotinilation experiments carried out in human, for both overexpressed and 
endogenous proteins. During our fluorescence studies carried out in several mouse cell lines, 
we have never observed a plasma membrane staining related to endogenous hCtr2. To rule out 
the possibility that lack of plasma membrane detection was due to incorrect fixation-
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permeabilization of the cells we employed two different protocols. Interestingly while 
detection of endogenous hCtr1 on the plasma membrane was abrogated using 
paraformaldehyde and Triton-X, it was clearly visible using methanol and saponin. Instead 
the mCtr2Ab signal was not affected by the protocol and in both cases the staining was 
exclusively intracellular and perinuclear.  
Despite the results presented by Bertinato and colleagues seem controversial, further studies 
will be required to verify the possibility of mammalian Ctr2 to localize or traffic to the plasma 
membrane. One hypothesis that could explain the staining on the plasma membrane only in 
human cells but not in mouse cells could be the presence in the human genome of a 
alternative Ctr2 variant not found in the mouse genome. Such variant differs from the more 
common and conserved mammalian Ctr2 for the additional presence of 60 aminoacids in the 
N-terminal of the protein (Zhou and Gitschier, 1997). The N-terminal sequence could harbor 
signals driving the protein to the plasma membrane. Further studies will be required to 
characterize this form and its putative role in copper metabolism. 
Alternatively the two distinct staining patterns reported by the L’Abbe group could suggest 
that endogenous and over-expressed hCtr2 may localize in two different compartments 
(Bertinato et al., 2008). It is known that overexpression of proteins in cells can alter their 
proper localization (Miyashita, 2004). This hypothesis is supported by our results too, even if 
we cannot rule out the possibility that the antibody developed in Dr. Thiele’s laboratory may 
recognize a specific protein other than Ctr2 not only by immunoblot but also by indirect 
immunofluorescence. 
Two more indirect observations support the hypothesis that Ctr2 does not localize in 
lysosomal membranes, and this mis-localization might be due to overexpression of the 
epitope tagged Ctr2. A general signature of lysosome membrane proteins is a high degree of 
glycosilation aimed to protect them from the proteolytic enzymes in the lysosomal lumen 
(Eskelinen et al., 2003) but immunoblot and lacking of glycosylation consensus sequences 
would suggest that Ctr2 is not glycosylated. Furthermore two independent mass spectrometry 
based proteomics studies aimed to map the lysosome proteome did not identify Ctr2 among 
the lysosomal resident membrane proteins (Bagshaw et al., 2005; Schröder et al., 2007). 
Interestingly in the Ctr1 null cell lines, where by immunoblot we observed a constitutive 
downregulation of the 15kDa protein, we detected a unique Ctr2 immunostaining pattern. 
Surprisingly while the overall staining intensity was not different from the one detected in 
wild type mouse embryonic cell lines, we noticed a characteristic staining of intracellular 
granules similar. Such structures reminded us the same structures co-localizing with 
overexpressed human Ctr2, indeed they were positive for LAMP1 staining, proving they 
belonged to the lysosomal system. 
This result led us to perform an analysis of conserved motifs in the primary sequence of 
mammalian Ctr2 proteins, which revealed the presence of at least two different putative 
lysosomal targeting sequences highly conserved in all species analyzed. A D[E]XXXL[LI] in 
the N-terminus of the protein, preceded by a conserved serine, could suggest the possibility 
that upon phosphorylation mediated activation, this signal may mediate Ctr2 lysosomal 
targeted degradation, as it was demonstrated for tow cell surface receptors, CD3 (Dietrich et 
al., 1994; Pitcher C et al., 1999) and CD4 (Pitcher C et al., 1999). Three putative YXXØ 
signals, two of which are preceded by a glycine may also be involved in lysosomal targeting. 
It is not clear if these tyrosine motives are accessible to the sorting machinery or not, given 
their proximity to the putative transmembrane domains. Furthermore is currently unknown 
that two distinct targeting signals in the same protein affect trafficking to the lysosomes 
(Braulke and Bonifacino, 2008). Interestingly these three motives are also present in the 
animal Ctr1 sequence. Given the evidences that binding of copper to the MXXXM motif may 
induce conformational change (De Feo et al., 2009), and the same motif is essential for copper 
dependent Ctr1 internalization and degradation (Guo et al., 2004) it is possible the two 
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tyrosine based signals flanking the MXXXM motif, might become exposed after copper 
binding and therefore mediating the copper dependent internalization and degradation of both 
Ctr1 and Ctr2. 
Notably it has been shown that over-expression of proteins bearing either type of signal leads 
to saturation of the sorting machinery, affecting either localization or recycling of other 
proteins containing the same signals (Marks et al., 1996). In case that the tyrosine based 
signals shared by Ctr1 and Ctr2 are responsible for copper induced Ctr1 internalization, it is 
possible that the increased copper uptake activity induced by hCtr2 overexpression previously 
reported  (van den Berghe et al., 2007; Bertinato et al., 2008), may be due to inhibition of 
downregulation of human and not directly correlated to Ctr2 activity. 
An other important goal of the research was to study the phenotype induced by RNAi 
mediated knockdown of Ctr2 in mouse cells, in order to shed light about its function and 
putative role in copper homeostasis.  
When we tested Ctr1 levels in Ctr2 silenced cells, we discovered that also the expression of 
the Ctr1 fragment was significantly reduced compared to control cells, while the full and 
glycosylated form seemed unaffected. This intriguing observation had a major drawback in 
determining Ctr2 activity, because downregulation of Ctr1 and consequent copper uptake 
reduction would mask Ctr2 activity. 
Lack of data excluding that Ctr1 downregulation is not due to off-target effects of Ctr2 
targeting RNAi oligos, it’s only speculative to hypothesize that Ctr1 expression is directly 
affected by Ctr2 expression levels, possibly by a post-transcriptional regulation mechanism. 
However if confirmed, this result would suggest that Ctr1 and Ctr2 are not only regulated in a 
coordinate way, but also able to reciprocally modulate each other’s expression. 
Based on the results present in this research and the bibliographic reports, it can be proposed a 
model where mammal Ctr2 is mainly localized in small cytoplasmic vesicles containing 
copper pools and possibly belonging to the Trans Golgi Network. In this model Ctr2 
expression is coordinated with Ctr1 expression in a copper dependent and in a copper 
independent way. In the copper dependent way an excess of copper induces downregulation 
of both membrane transporters while copper starvation induces upregulation of their 
expression. In the copper independent way Ctr1 expression is required for Ctr2 expression 
and localization and lack of Ctr1 induces Ctr2 degradation possibly through trafficking of 
Ctr2 in the lysosomes mediated by lysosomal targeting signals.  
This regulation may suggest that the cells interpret the absence of Ctr1 as signal for excess of 
copper in the extracellular environment, and this signal triggers Ctr2 degradation as defensive 
mechanism to avoid copper overload.  
A possible mechanism allowing the coordinate regulation of Ctr1 and Ctr2 expression in 
response to copper levels is shown in Fig. 1 
In higher eukaryotes a Ctr1-Ctr2 intermolecular interaction in intracellular compartment 
where Ctr2 localizes at steady state levels would mask the lysosomal sorting signals harbored 
in both proteins, preventing them to be bound and recognized by the sorting machinery.  
This interaction could be either inhibited directly by high concentrations of copper, or by a 
third protein “sensing” copper overload. 
In either case this copper dependent interaction could be the checkpoint influencing the 
destiny of Ctr1 after internalization from the plasma membrane as well the destiny of Ctr2: 
low copper levels would allow the interaction and the partial recycling of Ctr1 to the plasma 
membrane, not affecting Ctr2 steady state levels (Fig. 1 upper panel). Instead high cytosolic 
copper concentrations would cause inhibition of the Ctr1-Ctr2 interaction re-directing both 
proteins to the lysosomes for protein degradation (Fig.1 lower pane). 
Lack of either protein would cause a disruption of the “homeostatic balance” leading to a 
massive and constitutive trafficking of the counterpart to the lysosomes for protein 
degradation. This scenario could explain why in Ctr1 null cells Ctr2 protein levels are 
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extremely low, and why Ctr2 RNAi mediate knockdown causes a similar decrease in Ctr1 
protein levels, in particular of the proteolytic cleaved form of Ctr1. 
A physical interaction and a copper dependent co-regulation of two distinct members of the 
Ctr family has been described in the yeast S. pombe  (Zhou and Thiele, 2001). 
This model does not exclude but actually favors the possibility suggested by bibliographic 
and structural data that Ctr2 might function as an intracellular low affinity copper transporter. 
The Ctr1-Ctr2 interdependent regulation would allow the cells to coordinate copper influx 
from the extracellular environment and from the intracellular stores. 
More studies will be required to confirm this hypothesis and to determine the functions and 
the role in copper homeostasis of this elusive protein. 
 
 
 
 
Figure 1. Proposed model for Ctr1/Ctr2 regulation in which interaction between the two Ctr 
members function as a checkpoint. At low copper concentrations (upper figure) when Ctr1 is 
internalized can interact with Ctr2 in an intracellular compartment. This interaction stabilizes 
both proteins and Ctr1 can be recycled to the plasma membrane. At high copper 
concentrations (lower figure) when Ctr1 is internalized the interaction is inhibited either by 
copper or a copper sensing protein binding protein inhibit their interaction cannot interact 
Both proteins are targeted to the lysosomes where they are degraded.  
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APPENDIX 
 
 
 
Development of a LC-mass based method for detection of PsP 
(Paralytic Shellfish Poisoning) biotoxins 
 
 
 
INTRODUCTION 
 
Algal biotoxins are small biomolecules produced by marine microalgae, responsible for food 
intoxications in human and animals and are divided in five groups, such as, PSP (Paralytic 
Shellfish Poisoning), DSP (Diarrhetic Shellfish Poisoning), ASP (Amnesic Shellfish 
Poisoning), NSP (Neurotoxic Shellfish Poisoning) e CFP (Ciguatera Fish Poisoning) 
(Hallegraeff, 2003). 
The toxins belonging to the PsP group are mainly produced by marine dinoflagellates such as 
Alexandrium catenella, A. cohorticula, A, fundyense, A. fraterculum, A. leei, A. minutum, A. 
tamarense, Gymnodinium catenatum e Pyrodinium bahamense var. compressum.  
Algal bloom can give rise to characteristic water colorations, known as “red tide”, but an 
association between these events and production of biotoxins has not been established. 
PsP group includes more than 21 highly hydrophobic toxins with a common tetrahydropurine 
backbone. Based on the functional group harbored in the side chain they can be divided in 
three groups: carbamoyl (R=OCONH2) the most toxic, decarbamoyl (R=H) and N-
sulfocarbamoyl (R= OCONHSO3-) the least toxic (Fig. 1). The most toxic PsP is saxitoxin, 
with a LD50 in the mouse dependent on the administration way: 10µg/Kg intraperitoneal, 
263µg/Kg oral and  <2µg/Kg respiratory.  
Common symptoms following PsP intoxication include: nausea, vomiting, diarrhea, 
abdominal pain, and tingling or burning lips, gums, tongue, face, neck, arms, legs, and toes. 
Shortness of breath, dry mouth, a choking feeling, confused or slurred speech, and lack of 
coordination are also possible. Death can occur after 2-12h in case of ingestion of high 
concentrations of toxins as a result of respiratory block. 
Italian and European legislations demand PsP analysis and quantitation on all seafood 
products (Rettifica del Regolamento (CE) n°853/2004 del Parlamento Europeo e del 
Consiglio; Regolamento (CE) n°2074/2005 della Commissione; Regolamento (CE) 
n°1664/2006 della Commissione; Gazzetta Ufficiale della Repubblica Italiana, 2002).   
The official method for PsP identification is the mouse bioassay.  
Recently a HPLC (High Pressure Liquid Chromatography) based method has been certified 
(Lawrence et al., 2005), but such method is time consuming and analysis of samples with 
complex toxin profiles can take up to three days of work. 
My activity at the Centro Ricerche Marine-Cesenatico focused on the development of a LC-
mass method to analyze and identify the biotoxins belonging to the PsP group as well as other 
hydrophilic algal bioxotins. 
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Figure 1. Chemical structure of PsP toxins. 
 
 
 
MATERIALS AND METHODS 
  
To set up and optimize the method it was used the following PsP certified standard (NRCC, 
National Research Council of Canada, Halifax): saxitoxin, (STX), neosaxitoxin (NEO), 
decarbamoylsaxitoxin (dcSTX), gonyautoxin 1-2-3-4(GTX1, GTX2, GTX3, GTX4), 
gonyautoxin 5 (B1), decarbamoylsaxitoxin 2 (dcGTX2) and decarbamoylsaxitoxin 3 
(dcGTX3). 
In addition we tested also certified standards of Domoic Acid (DA) e Tetradotoxin (TTX). 
Mass spectral analyses were performed Varian 1200 L triple-quadruple, equipped with 
interface API/ESI. To increase the specificity of the signal we performed the analysis in 
selected reaction monitoring (SRM) and the transitions selected are reported in 
chromatograms. 
To calibrate the instrument we infused in the mass spectrometer 1ppm of each standard and 
we acquired MS/MS breakdown plots in selected reaction monitoring mode (SRM) in positive 
and negative ion mode. For each standard we selected the transition with the highest intensity. 
Transitions selected are reported in chromatogram. 
It was tested two different HILIC (Hydrophilic Interaction Chromatography) columns:  a non-
functionalized one (ATLANTIS™ HILIC Silica 5µm 2,1x150mm 100Å, Waters) and other 
harboring amide groups (TSK-GEL Amide-80 5µm 2,0x250mm, Tosoh Bioscience). 
For each column we tested different mobile phases studying the effect of ACN percentage, 
pH, salt concentration and TFA addition on peak shape, resolution and sensitivity. 
The optimized method involves the elution by gradient using the following mobile phases: 
Mobile phase A: 64% ACN 36% H20, 2mM ammonium formate 3,5mM formic acid  
Mobile phase B: 64% ACN 36% H20, 4mM ammonium formate 10mM formic acid, 0,01% 
TFA (trifluoroacetic acid). 
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Figure 2. Scheme of the gradient employed in the method. 
 
 
 
Two different SPE (solid phase extraction) cartridges were tested. 
The first, a weak cation exchange column (BakerBond 500mg/3ml), was conditioned with 
1ml of 0,01% ammonium formate, loaded with 1ml of sample, washed once with 1ml of 
water, further washed with 5mf ACN and eluted with 1ml of TFA 0,1%.  
The second, a mixed mode cationic exchange (MCX Waters 60mg/3ml), was conditioned 
with MeOH 100%, equilibrated with 1ml 0,01% ammonium formate, loaded with 1ml of 
sample, washed once with 1ml of water, further washed with 1mf ACN and eluted with 1ml 
of TFA 0,1%. 
Whole mussel soft tissues from negative samples were pooled and homogenized with a 
grinder. 
5g of homogenate were extracted with 15ml of formic acid 0,1%, homogenizing 3min at 
10000rpm with an Ultra Turrax and centrifugating at 3600rpm per 10min. The supernatant 
was contaminated with standards of STX and GTX1-4 at a final concentration of 1ppm each. 
 
 
 
RESULTS AND DISCUSSIONS 
 
HILIC chromatography was initially employed to separate and analyze by mass spectrometry 
peptides and nucleic acids, given its strong retention capacity for polar compounds and its 
high compatibility with ESI (electrospray ionization) technology (Alpert, 1990). 
Analytes interact with a silica based stationary phase through hydrophilic interactions and 
probably ionic exchange interactions, the mobile phase containing a high percentage of 
organic solvents and low salt concentration favors ionization of the compounds in the ESI 
chamber. 
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As expected for both columns the retention times of the PsP toxins were proportional to the 
net charge of the compounds in the mobile phase. In the early stages of the research we 
employed an un-functionalized HILIC Column (Waters), already available in the laboratory.  
Figure 3 shows a typical chromatogram of a PsP standard mixture using this column and 
applying the method proposed by Dell’Aversano et al., 2005. It is clear how this column 
cannot resolve toxins having the same net charge, like STX and NEO. Furthermore the single 
charged toxins, B1, GTX1-4 are not only not resolved, but are poorly retained by the column. 
We then tested the TSK-GEL Amide-80, the same column employed in the published 
protocol, using the same chromatographic condition.  
As expected for both columns the retention times of the PsP toxins were proportional to the 
net charge of the compounds in the mobile phase, but the TSK-GEL Amide-80 was 
significantly more efficient in retaining all the standards analyzed, indeed retention times of 
double charged toxins almost double increased of several minutes, and retention times of 
single charged toxins shifted from 4min to almost 10min (Fig. 4). 
 
 
 
 
 
Figure 3. LC-mass analysis of a mixture of standards containing PsP toxins, Domoic Acid (DA) and 
Tetradotoin (TTX). Molecules were separated on an ATLANTIS™ HILIC Silica 5µm 2,1x150mm 
100Å, column (Waters) using the method proposed by D’Aversano et al. (2005) and analyzed in SRM 
mode. For each standard the selected reaction is reported. Scales are not adjusted. 
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In HILIC percentage of organic phase is the critical factor affecting the separation, and even 
small variations can result in dramatic change. In general pH and salt concentration of the 
running buffer have a lower influence in retention times but they also have a critically impact 
in the ionization in the ESI chamber, consequently variations in these parameters can affect 
simultaneously retention times and signal intensities (Strege, 1998). 
Despite the general improvement, it was observed a too broad peak shape of the double 
charged toxins that include the most toxic compounds. It was previously reported that TSK-
GEL Amide-80 allows to selectively manipulating retention times by changes in the pH and 
salt concentration of the running buffer (Gou and Gaiki, 2005). Therefore it was decided to 
investigate the effect of these two factors.  
 
 
 
 
Figure 4. LC-mass analysis of a mixture of standards containing PsP toxins, Domoic Acid (DA) and 
Tetradotoin (TTX). Molecules were separated on a (TSK-GEL Amide-80 5µm 2,0x250mm, Tosoh 
Bioscience) using the method proposed by D’Aversano et al. (2005) and analyzed in SRM mode. For 
each standard the selected reaction is reported. Scales are not adjusted. 
 
 
 
Lowering the pH decreased retention times of all the standards with a more marked effect on 
the double charged toxin, but in general it did not influence significantly the signal intensity 
(data not shown). 
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Figure 5. Effect of salt concentration (upper panels) and TFA addition (lower panels) in the mobile 
phase on the retention times and peak intensity of STX (left) and GTX4 (right). Scales are adjusted at 
the same level. 
 
 
 
Small increases in the salt concentration had a significant effect on the retention times of the 
double charged compound STX: increasing the concentration of the ammonium formate from 
2 to 8mM almost halved the retention time, improving peak shape and maximum peak 
intensity (Fig. 5 upper left panel). 
The same variation in salt concentration had a similar but less pronounced effect on retention 
time of the single charged toxin GTX, but resulted in a strong reduction of the signal (Fig. 5 
upper right panel). 
The critical factor that dramatically improved the peak shape and signal intensity of the 
double charged PsP members (STX, NEO and dcSTX) was the employment in the mobile 
phase of low concentration of TFA (Fig. 5 lower panel). 
 59 
It is likely that the interaction between the compounds and the column is mainly influenced 
by ionic bounds between the negatively charged silanol groups of the column and the 
positively charged guanidinic groups of the compounds.  
 
 
 
 
Figure 6. LC-mass analysis of a mixture of standards containing PsP toxins, Domoic Acid (DA) and 
Tetradotoin (TTX). Molecules were separated on a (TSK-GEL Amide-80 5µm 2,0x250mm, Tosoh 
Bioscience) using the method we developed and analyzed in SRM mode. For each standard the 
selected reaction is reported. Scales are not adjusted. 
 
 
 
These ionic bounds probably cause the characteristic “tailing peak” observed for the double 
charged toxins and it is likely that TFA can inhibit such interactions resulting in a more 
symmetric peak.  
Usually TFA, as other ion pairing agents, is not considered compatible with ESI ionization 
since it can induce a strong signal suppression, but recently it was shown that simultaneous 
use of TFA and other volatile acids such as ammonium formate, strongly reduces signal 
suppression (Shou and Naidong, 2005; Naldi et al., 2006). 
Similarly to what observed with increasing salt concentrations, also addition of TFA caused a 
net decrease in signal intensity of single charged toxin (Fig. 5 lower panel).  
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Figure 7.  LC-mass analysis of a STX (left) and GTX1-4 (right) standard mixture was loaded on a 
weak ion exchange SPE cartridge (Bakerbon). Loadings, washes and eluates were separated on a 
(TSK-GEL Amide-80 5µm 2,0x250mm, Tosoh Bioscience) using the method developed and analyzed 
in SRM mode. The last row represents analysis of the amount of each standard identical to the one 
loaded on the SPE cartridges. For each standard the selected reaction is reported. Scales are not 
adjusted. 
 
 
Given these results we figured that a gradient elution (Fig.1) would have been ideal in order to 
obtain a better elution and peak shape for double charged toxins without inducing signal 
suppression for the single charged toxin (Fig. 6). 
Of the two SPE cartridges tested for sample preparations the cation exchange (Bakerbond) 
resulted in a good recover of STX and GTX (Fig. 7). 
In the mixed mode cartridge elution of the double charged toxins was possible only using 
high salt concentrations or strong alkaline agents, that are not compatible with ESI analysis 
(data not shown). 
Analysis of mussel extracts contaminated with PsP standards showed a matrix effect 
consistent in shifting of the retention times and especially signal suppression. Currently, we 
are investigating strategies to overcome such matrix effect. 
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